


















































repressor	 of	 neuronal	 developmental	 programme	 in	 non-neuronal	 lineages,	 recently	
described	as	a	main	actor	in	the	maintenance	of	the	GSCs’	tumorigenic	competence	as	its	
knockdown	 strongly	 impairs	GSCs	 stemness	both	 in	 vitro	and	 in	 vivo.	However,	 REST	 is	
critical	 for	 restraining	 neuronal	 cellular	 identity	 in	 various	 tissues,	 so	 that	 a	 targeted	
therapy	to	this	transcriptional	repressor	is	likely	to	present	numerous	side	effects.	
Here,	by	taking	advantage	of	a	Tet-on	system	for	the	manipulation	of	REST	expression	in	
both	 human	 GSCs	 and	 Neural	 Stem	 Cell	 lines	 (hNSCs),	 we	 performed	 a	 transcriptomic	
profiling	analysis	in	order	to	identify	novel	tumour-specific	REST-regulated	functions	and	
molecular	targets.	Our	analyses	confirmed	the	previously	reported	roles	of	REST	in	neural	
tissues	 and	 enlightened	 novel	 REST	 functions	 in	 hGSCs,	 including	 the	 regulation	 of	
alternative	hGSCs	identity/state.	Finally,	analysis	of	hGSC-specific	REST-regulated	genes	in	





















targeting	 the	 tumorigenic	 stem	 compartment	 of	 GBM,	 and	 raises	 central	 questions	 in	
tumour	biology:	(i)	how	tumorigenic	competence	is	established	in	cancer	stem	cells	and	(ii)	
how	 we	 could	 exploit	 this	 information	 in	 order	 to	 develop	 targeted	 and	 effective	
therapeutic	options.	
Previous	studies	suggest	that	pathways	regulating	multipotency	in	physiological	hNSCs	are	
also	 involved	 in	 sustaining	 GBM	 tumorigenesis.	 The	 Repressor	 Element	 1	 Silencing	
Transcription	factor	(REST)	has	been	identified	as	master	regulator	of	neuronal	genes	 in	
non-neuronal	cells,	in	order	to	restrict	their	expression	to	the	nervous	system.	Tissue-	and	
cell-specific	 functions	 of	 REST	 have	 been	 subsequently	 identified.	 In	 adult	 hNSCs,	 REST	
maintains	 self-renewal	 and	 represses	 neuronal	 differentiation	 in	 order	 to	 preserve	 the	
stem	 cell	 pool.	 Similarly,	 hGSCs	multipotency	 is	 promoted	by	REST	 as	 its	 loss	 results	 in	










knock-down	 or	 overexpress	 REST	 in	 an	 inducible	 way.	 In	 order	 to	 identify	 the	
differential	role(s)	of	REST	in	hGSCs	and	hNSCs,	we	generated	stable	tetracycline-
inducible	cell	 lines	 for	 the	controlled	REST	overexpression	or	 silencing.	 In	 these	













































































































brain	 tumours	 (Subramanian	et	al.,	 2002).	 These	 tumours	most	 commonly	derive	 from	
breast	cancer,	lung	cancer,	and	melanoma	(Johnson	and	Young,	1996)	and,	as	subsidiary	







per	 year,	 corresponding	 to	 6.9	 per	 100.000	 people.	 They	 result	 in	 4.9	 per	 100.000	
individuals’	 mortality	 rate1.	 Even	 though	 they	 all	 derive	 from	 the	 CNS,	 primary	 brain	















putative	 cell	 of	 origin	 is	 historically	 considered	 to	 separate	 gliomi	 from	 non-gliomi,	













Glioma	 represents	 the	 most	 common	 brain	 tumour,	 accounting	 for	 the	 70%	 of	 the	
intracranial	neoplasia	diagnosed	every	 year	 in	 the	adults	 (Parsons	et	al.,	 2008).	Among	


















































































slightly	more	affected	 than	 females	 (1.6:1)	 and	whites	 than	blacks	 (2:1)	 (Ostrom	et	al.,	
2014).	 The	 only	 environmental	 agents	 confirmed	 to	 increase	 the	 relative	 risk	 for	
glioblastoma	is	ionizing	radiation	of	the	brain	(Neglia	et	al.,	2006;	Ron	et	al.,	1988;	Sadetzki	
et	 al.,	 2005).	 However,	 these	 do	 not	 include	 radiation	 scans	 performed	 according	 to	
diagnostic	procedures	(Brada	et	al.,	1992;	Minniti	et	al.,	2005).	The	correlation	between	
either	 the	 use	 of	 mobile	 phone	 or	 the	 exposure	 to	 electromagnetic	 fields	 and	 the	









cases,	 likely	 because	 of	 a	 poor	 adaptation	 of	 GBM	 cells	 to	 the	 metabolic	 and	 the	




the	 disease	 remains	 stable	 over	 time.	More	 frequently	 GBM	 exhibits	 suddenly,	 with	 a	
severe	impact	on	the	quality	of	life	(Keime-Guibert	et	al.,	2007;	Pérez-Larraya	et	al.,	2011;	
Roa	 et	 al.,	 2004;	 Taphoorn	 et	 al.,	 2005).	 GBM	 may	 manifest	 with	 headache,	 nausea,	
seizures,	 memory	 loss	 and	 confusion	 due	 the	 intracranial	 hypertension	 caused	 by	 the	
expansion	 of	 the	 tumour	mass	within	 the	 cranium.	Moreover,	 patients	with	 GBM	may	
present	 with	 a	 range	 of	 neurologic	 deficits	 whose	 nature	 depends	 on	 the	 brain	 area	
interested	 by	 the	 disease	 (Figure	 1.1A)	 (Wen	 and	 Kesari,	 2008).	 Frontal	 lobe	 tumours	
commonly	determine	personality	changes	and	mood	disorders	that	can	be	mistaken	for	
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symptoms	 associated	 to	 physiologic	 ageing	 process.	 About	 20%	 of	 patients	 exhibit	
sensorimotor	alterations	as	presenting	symptom	and	5%	of	patients	present	with	aphasia	
with	 tumours	 arising	 in	 proximity	 of	 the	 Broca’s	 and	 the	 Wernicke’s	 area	 on	 the	 left	
hemisphere	(Yuile	et	al.,	2006).	Temporal	lobe	tumours	frequently	result	in	epilepsy,	that	
represent	one	of	 the	main	presenting	 symptoms	 (24-68%	GBM)	 (Breemen	et	al.,	 2009;	





Figure	 1.1.	 GBM	 localisation	 and	 diagnosis.	 A.	 Human	 cerebral	 cortex	 representation	 with	
frequency	 of	GBM	 in	 the	 different	 cortical	 areas.	 Approximate	 localisation	 of	 eloquent	 areas	 is	
highlighted:	(i)	orange	–	Broca’s	area	and	(ii)	violet	–	Wernicke’s	area	controlling	speech;	(iii)	yellow	
–	primary	motor	cortex	regulating	voluntary	movement;	 (iv)	 light	blue	–	primary	somatosensory	









images	 indicative	 of	 either	 oedema	 or	 noncontrast-enhancing	 tumour	 (Figure	 1.1B).	





with	 the	 aim	 of	 removing	most	 of	 the	 tumour	mass.	 This	 treatment	 increases	median	
overall	 survival	 from	six	 to	12	months	respect	 to	biopsy	only	 (Figure	1.2A)	 (Yuile	et	al.,	




compared	 to	 radiotherapy	 alone	 (Figure	 1.2B)	 (Hegi	 et	 al.,	 2005;	 Stupp	 et	 al.,	 2005;	
https://emedicine.medscape.com/).	Postoperative	radiotherapy	aims	at	reducing	tumour	












(PFS)	 (Figure	 1.2C,	 Bobola	 et	 al.,	 2015).	 Despite	 this	 dismal	 increase	 in	 PFS	 and	 OS	
associated	 to	 TMZ	administration,	 the	 side	effects	 that	 accompanies	 the	 treatment	 are	
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use	 of	 bevacizumab,	 an	 anti-vascular	 endothelial	 growth	 factor	 (VEGF)	 recombinant	
antibody,	in	adult	patients	with	recurrent	GBM.	This	treatment	is	based	on	the	evidence	
that,	in	order	to	progress	and	keep	growing	a	tumour	needs	to	sustain	a	high	metabolic	
demand.	 The	 increasing	 nutrient	 supply	 is	 achieved	 through	 continuous	
neovascularisation,	 an	 event	mainly	 governed	 by	 the	 VEGF	 signalling	 (Batchelor	 et	 al.,	
2014).	Thus,	the	administration	of	antibodies	anti-VEGF	would	impede	the	VEGF	binding	to	
its	 receptor	and	 induce	 tumour	 starvation,	 limiting	 the	 tumour	growth	capabilities.	The	
approval	of	bevacizumab	is	based	on	a	still	ongoing	multicentre,	randomised,	open-label	
clinical	phase	III	 trial	 in	which	the	addition	of	bevacizumab	to	 lomustine	chemotherapy3	
compared	to	lomustine	alone	was	analysed.	The	first	results	of	the	trial	indicate	that	the	
combination	therapy	is	not	effective	on	patients’	overall	survival,	thus	failing	to	meet	the	
primary	 end-point	 of	 the	 study.	However,	 it	 does	 prolong	 PFS	 from	1.5	 to	 4.2	months,	
therefore	 improving	 the	 quality	 of	 life	 of	 recurrent	 GBM	 patients	 (Wick	 et	 al.,	 2017;	
https://www.gene.com/;	 EORTC	 26101	 ClinicalTrials.gov	 number,	 NCT01290939).	 In	
Europe,	 bevacizumab	 is	 indicated	 for	 the	 treatment	 of	 different	 type	 of	 cancers	 in	
combination	with	 chemotherapeutics.	 In	 2014,	 the	 European	Medicines	 Agency	 (EMA),	
rejected	the	request	to	change	the	marketing	authorisation	of	bevacizumab	for	the	use	in	
newly	 diagnosed	 GBM	 in	 combination	 with	 radiotherapy	 and	 TMZ.	 Interestingly	 the	
rejection	was	based	on	the	same	result	that	led	the	FDA	to	approve	the	use	of	bevacizumab	

























clinical	 analyses	 showing	 a	 slightly	 different	 outcome	 between	 primary	 and	 secondary	
GBM,	with	primary	entities	having	a	median	OS	of	4.7	months	vs.	7.8	months	in	secondary	
diseases	(Ohgaki	et	al.,	2004).	The	first	evidence	of	distinct	genetic	alterations	between	
GBM	subtypes	were	 reported	 in	1996	by	Kleihues	and	Ohgaki.	 Epidermal	growth	 factor	
receptor	 (EGFR)	 overexpression	 and	 tumor	 protein	 p53	 (TP53)	 mutations	 were	 initially	
described	as	mutually	exclusive	in	primary	and	secondary	glioblastomi	(Watanabe	et	al.,	
1996),	suggesting	not	only	the	possibility	to	discriminate	between	the	two	phenotypes,	but	
importantly,	 the	 existence	 of	 different	 genetic	 evolution	 pathways	 that	 may	 require	













Other	 than	 patients’	 age	 distribution,	 the	 genetic	 differences	 between	 primary	 and	
secondary	GBM	also	determine	a	divergent	preferential	 location	of	 the	 tumour.	 IDH1/2	
mutant	GBM,	 as	well	 as	WHO	 II	 astrocytomi	with	 IDH1/2	mutations	 are	more	 likely	 to	
develop	in	the	frontal	lobe	and	to	present	seizures	as	initial	symptom	(Stockhammer	et	al.,	
2012),	 while	 IDH1/2	 wild	 type	 GBM	present	 widespread	 distribution	 (Lai	 et	 al.,	 2011).	
Similarly,	oligodendrogliomi	with	1p/19q	loss	form	preferentially	in	the	frontal	lobe	(Laigle-











this	 direction	 were	 proposed	 by	 a	 delegation	 of	 the	 International	 Society	 of	
Neuropathology	(ISN)	in	Haarlem,	Netherlands,	in	May	2014	and	then	revised	by	the	latest	
WHO	classification	of	2016.	The	“ISN	Haarlem	guidelines”	indicate	brain	tumour	diagnosis	
should	 be	 stratified	 hierarchically	 in	 layers,	 integrating	 histological	 classification,	 WHO	


























The	 mesenchymal	 subtype	 present	 often	 hemizygous	 deletion	 of	 the	 17q11.2	 region	
harbouring	NF1	 gene	and	a	 low	expression	 level	 of	NF1.	 This	 subtype	 is	 named	after	 a	
peculiar	expression	of	mesenchymal	markers,	such	as	chitinase-3-like	protein	1	 (CHI3L1)	
and	MET	 other	 than	 the	 astrocytic	markers	CD44,	MER	proto-oncogene	 tyrosine	 kinase	
(MERKT)	 and	 tumor	 necrosis	 factor	 (TNF)	 and	 nuclear	 factor	 kappa	 B	 (NF-κB)	 families’	
pathways	that	might	be	associated	to	the	presence	of	white	cells	and	necrosis.	
The	 focal	 amplification	of	 the	4q12	 locus,	 containing	PDGFRA,	 has	been	observed	 in	all	
glioblastoma	 subtypes,	 though	 with	 a	 particular	 high	 frequency	 in	 the	 proneural	
phenotype.	Consistent	with	a	marked	prevalence	of	IDH	mutations,	most	of	the	secondary	
GBM	and	an	overall	younger	age	of	patients	are	characteristics	of	this	class.	Finally,	 the	
proneural	 group	 shows	 a	 high	 expression	 of	 oligodendrocytic	 development	 genes	 and	
proneural	 genes,	 such	 as	 doublecortin	 (DCX),	 ascheate-scute	 family	 bHLH	 transcription	











patients	 treated	 with	 an	 intensive	 therapy,	 which	 is	 now	 the	 standard	 treatment	 of	
concurrent	chemotherapy	and	radiotherapy	plus	more	than	three	cycles	of	chemotherapy,	
with	 a	 less	 intensive	 therapy	 in	 which	 the	 patients	 were	 treated	 either	 with	 a	 non-
concurrent	chemotherapy	and	radiotherapy	or	less	than	four	cycles	of	chemotherapy.	Only	
the	 classical	 and	 mesenchymal	 phenotypes	 resulted	 more	 sensitive	 to	 an	 aggressive	





Even	 if	 they	 are	 still	 not	 considered	 in	 the	 day	 to	 day	 clinical	 practice,	 the	 molecular	
subclasses	of	GBM	are	now	widely	 used	 in	 research	 in	 the	 effort	 of	 identifying	 a	more	
precise	 therapy.	 For	 instance,	 the	 concurrent	 use	 of	 bevacizumab	 in	 addition	 to	 the	
standard	chemo	and	radiotherapy	in	newly	diagnosed	GBM	was	shown	to	prolong	PFS,	but	




on	 the	 mesenchymal	 GBM	 reported	 a	 significantly	 shorter	 OS	 associated	 to	 a	 high	
mesenchymal	signature	and	a	lower	response	to	radiotherapy	(Bhat	et	al.,	2013).		
However,	concerns	about	the	reliability	of	the	TGCA	molecular	classification	might	be	risen	




of	 five	 freshly	 resected	GBM	 samples	 describing	 tumours	 composed	 of	more	 than	 one	










can	 be	 used	 for	 lineage	 classification	 (Kim	 and	 Costello,	 2017).	 As	 a	 consequence,	 the	
molecular	 classification	 of	GBM	based	 on	DNA	methylation	 patterns	 is	 supposed	 to	 be	
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Traditionally,	 a	 tumour	 is	 conceived	 as	 a	 heterogeneous	 cellular	mass	 yet	 presenting	 a	
homogeneous	proliferative	ability	and	sharing	the	same	genetic	alterations.	According	to	
the	traditional,	or	stochastic	view	of	tumour	biology,	every	cancerous	cell	would	be	able	to	
proliferate	 extensively	 and	 to	 generate	 secondary	 tumours.	 The	 heterogeneity	 would	
derive	stochastically	 from	both	 intrinsic	and	extrinsic	 influences	able	to	activate	the	cell	
potential	 asynchronously,	 and	 determine	 the	 proportion	 of	 tumour	 cells	 destined	 to	
proliferate	 while	 others	 will	 differentiate	 (Beck	 and	 Blanpain,	 2013).	 However,	 when	
analysed	for	their	tumorigenic	potential,	using	serial	xenotransplantation	in	animal	models,	
not	all	the	tumour	cells	are	able	to	generate	a	secondary	tumour.	The	first	shake	to	the	
traditional	 view	 has	 been	 given	 by	 Bonnet	 and	 Dick,	 that	 in	 1994	 identified	 of	 a	
subpopulation	of	acute	myeloid	leukemia	(AML)	cells	with	a	unique	ability	of	regenerating	
the	 tumour.	 Even	 though	 they	 represented	 only	 0.1%	 of	 total	 tumour	 cells,	 the	
CD34+/CD38-	 AML	 cells	 were	 the	 only	 able	 to	 phenocopy	 the	 original	 tumour	 once	







tissues	 with	 an	 acquired	 ability	 of	 eluding	 the	 physiological	 growth	 regulation.	 A	








limited	 but	 burning	 proliferative	 capability	 and	 (iii)	 differentiated	 effector	 cells	 that	
characterise	the	tissue	functions	and	physiology	with	no	renewal	capacity	and	constitute	
the	great	majority	of	the	cells.	The	progressive	acquisition	of	tissue-specific	features	and	
functions	 is	 therefore	 accompanied	 by	 the	 loss	 of	 renewal	 ability.	 Tightly	 controlled	





















Notch	 pathways	 controls	 self-renewal	 and	 inhibits	 differentiation	 of	NSCs,	 but	 has	 also	
been	 identified	as	 regulator	of	brain	CSC	 tumorigenesis	 (Androutsellis-Theotokis	 et	 al.,	
2006;	 Gaiano	 et	 al.,	 2000;	 Zhu	 et	 al.,	 2011).	 Similarly,	 other	 pathways	 governing	 self-




therapeutic	 failure	due	 to	 tumour	 relapses	 (Clarke	et	al.,	 2006).	Decades	after	 the	 first	









that	 took	 to	 the	 discovery	 and	 isolation	 of	 GSCs	 has	 been	 long	 and	 could	 not	 be	
accomplished	 without	 the	 description	 of	 neurogenic	 processes,	 and	 the	
subsequent/concomitant	characterisation	of	NSCs.	
The	 first	 observation	 of	 cell	 division	 in	 the	 adult	 rodents’	 brain,	 specifically	 in	 the	
subventricular	 zone	 (SVZ)	 lining	 the	 lateral	 ventricle,	 was	 reported	 in	 1961,	 when	




in	 the	post-natal	 and	adult	 life,	 in	 order	 to	preserve	 the	 complex	 integrity	 of	 the	brain	
(Altman,	 1962;	 Palmer	 et	 al.,	 1995).	 Using	 the	 same	 techniques,	 dividing	 cells	 were	
subsequently	revealed	also	in	the	dentate	gyrus	of	the	hippocampal	subgranular	zone	(SGZ)	
(Figure	2.1A,	Altman,	1963).	Neurogenesis	is,	however,	a	multistep	process	not	limited	to	
NSC	 proliferation,	 but	 consisting	 also	 of	 neuroblast	 migration	 to	 the	 final	 destination,	
differentiation	and	integration	into	neural	circuits.	It	was	therefore	the	detection	of	adult	
born	 neurons	 that	 proved	 adult	 neurogenesis	 to	 actually	 takes	 place.	 Altman	 and	 Das	
described	 the	 migration	 of	 postnatally	 born	 cells	 from	 the	 subventricular	 zone	 to	 the	
olfactory	 bulb,	 where	 they	 differentiate	 (Figure	 2.1B,	Altman,	 1969;	 Altman	 and	 Das,	
1965),	 and	 years	 later	 Kaplan	 and	 Hinds	 detected	 newly	 formed	 neurons	 in	 the	 adult	
dentate	 gyrus	 (Kaplan	and	Hinds,	 1977).	 The	main	neurogenic	 areas	 as	we	know	 them	
today	were	therefore,	discovered.	Studies	in	birds	confirmed	adult	neurogenesis	is	not	a	
specific	 features	 of	 mammals,	 and	 for	 the	 first	 time	 showed	 that	 adult	 born	 neurons	
functionally	 integrates	 into	 pre-existing	 neural	 circuits	 and	 are	 electrophysiologically	
competent	 (Goldman	 and	 Nottebohm,	 1983;	 Paton	 and	 Nottebohm,	 1984).	 Whether	







primates’	 dentate	 gyrus,	 including	humans,	 or	 it	 is	 lost	 during	 evolution	 (Sorrels	 et	 al.,	
2018).	Nevertheless,	 the	 isolation	of	adult	NSCs	 from	many	brain	 regions	suggest	 these	
cells	might	cover	functions	other	than	neurogenesis	(Lie	et	al.,	2002;	Palmer	et	al.,	1995,	
1999;	Shihabuddin	et	al.,	1997;	Tropepe	et	al.,	2000;	Weiss	et	al.,	1996).	NSCs	were	indeed	
demonstrated	 to	 exert	 the	 so-called	 “bystander	 effects”,	 releasing	 growth	 factors	 and	















In	 the	 late	 1980s	 pioneering	 studies	 started	 to	 set	 the	 conditions	 for	 culturing	 neural	
precursors	 in	 vitro.	 In	 1988,	 Ron	 McKay’s	 group	 described	 the	 use	 of	 a	 temperature	
sensitive	 variant	 of	 the	 oncogene	 SV40	 T	 antigen,	 to	 control	 neural	 progenitors’	
differentiation.	Cerebellar	Nestin-positive	foetal	cells	could	be	maintained	as	self-renewing	
neural	progenitors	at	33°C,	a	 temperature	permissive	 for	 the	oncogene	 to	be	active,	or	
pushed	to	differentiate	into	neurons	or	glia,	by	increasing	the	temperature	to	39°C.	Also,	
the	 authors	 noticed	 that	 differentiation	 could	 be	 induced	 by	 co-culturing	 neural	
progenitors	with	other	foetal	neural	cells	(Frederiksen	et	al.,	1988).	 It	became	gradually	




neural	 progenitors	 resulting	 from	 primary	 culture,	 pushing	 their	 proliferation	 while	














cultures.	 The	 hypothesis	 was	 to	 play	 with	 three	 components	 to	 find	 the	 right	 culture	



















most	 of	 the	 cells	 died	 after	 two	 days	 in	 culture,	 unsupported	 by	 the	 selected	 culture	
medium,	about	1%	of	them	adhered	to	the	culture	plate	and	proliferated.	Few	days	later,	
the	growing	colonies	detached,	forming	floating	spheres	of	nestin	immunoreactive	cells.	




neurosphere	 assay	 can	 be	 reiterated	 serially,	 increasing	 exponentially	 the	 quantity	 of	
neural	progenitors	in	culture.	When	transferred	to	poly-l-ornithine	coated	plates	and	left	
in	culture	for	21	days,	the	spheres	adhered	and	the	nestin-positive	cells	started	to	migrate	
out	 of	 the	 sphere	 and	 gradually	 differentiate	 in	 neurofilament-positive	 neurons	with	 a	
round	 soma	 and	 thin	 processes,	 or	 stellate-shaped,	 GFAP	 immunoreactive	 astrocytes	
(Reynolds	and	Weiss,	1992).	This	represented	a	ground-breaking	finding	not	only	for	the	






survival	 and	 proliferation	 of	 foetal	 hippocampal	 progenitors,	 while	 the	 adhesion	 was	
supported	by	coating	the	plastic	supports	with	poly-l-ornithine	and	laminin	(Gage	et	al.,	
1995;	 Palmer	 et	 al.,	 1995;	 Ray	 et	 al.,	 1993).	 Under	 these	 conditions	 the	 cells	 were	
maintained	in	culture	for	the	remarkable	time	of	one	and	a	half	years,	suggesting	a	virtually	
unlimited	 self-renewal	 capacity.	 Although	 representing	 a	 mixed	 population	 of	 cells	
expressing	 markers	 of	 progenitors	 as	 well	 as	 of	 more	 differentiated	 cells,	 the	 nestin	







The	 culture	 system	 developed	 by	 Gage	 were	 subsequently	 optimised,	 allowing	 the	
maintenance	of	pure	populations	of	NSCs	in	vitro,	anyway	preserving	their	multipotency.	
Conti	et	al.	identified	culture	conditions	to	convert	murine	embryonic	stem	cells	into	NSCs	
and	 applied	 them	 to	 the	 isolation	 of	 NSCs	 directly	 from	 murine	 foetal	 CNS.	 Primary	
forebrain	cells	were	harvested	and	cultured	in	presence	of	both	EGF	and	bFGF.	These	cells	
spontaneously	 produced	 neurosphere-like	 floating	 aggregates,	 subsequently	 moved	 to	
laminin-coated	wells	 to	 let	 them	 adhere.	 Cells	 outgrowing	 from	 these	 floating	 spheres	





mouse	 brain.	 Further	 evidences	 indicated	 these	 cells	 represent	 the	 resident	 stem	 cells	
within	the	neurospheres.	Not	only	these	implemented	culture	conditions	allowed	for	the	
first	time	to	maintain	in	vitro	pure	populations	of	NSCs,	but	they	could	also	be	applied	for	
the	 derivation	 of	 NSCs	 from	 human	 foetal	 brain.	 (Conti	 et	 al.,	 2005).	 NS	 cells	 were	
successively	 derived	 with	 high	 efficiency	 also	 from	 adult	 mouse	 and	 human	 brain,	














of	 CSCs	 from	 leukemia,	 Singh	 segregated	 glioma	 cells	 according	 to	 the	 expression	 of	
Prominin1/CD133,	a	transmembrane	glycoprotein	involved	in	NSC	maintenance,	but	also	
expressed	by	endothelial	and	hematopoietic	progenitors	 (Salven	et	al.,	2003;	Yin	et	al.,	
1997),	 determining	 that	 the	CD133+	brain	 tumour	 cells	 share	overlapping	 features	with	
NSCs.	These	cells,	that	were	consequently	termed	“brain	tumour	stem	cells”	(BTSCs),	can	
be	propagated	as	non-adherent	spheres	in	presence	of	growth	factors,	express	the	neural	




these	 experimental	 cancers	 presented	 histological	 features	 phenocopying	 the	
cytoarchitecture	and	behaviour	of	the	original	human	pathology.	The	ability	to	self-renew	
in	vivo	was	also	demonstrated	through	serial	transplantation	and	isolation	of	BTSCs	(Singh	




cell	 properties	 and	 tumorigenic	 capability,	 and	 therefore	 CD133	 could	 no	 more	 be	
considered	a	cancer	stem	cell	markers	for	brain	tumours	(Beier	et	al.,	2007).	
Even	 though	effective	 in	 enriching	NSCs,	 neurosphere	 condition	 is	 associated	 to	 critical	
problems:	 (i)	 the	efficiency	of	NSC	 isolation	 is	 low,	 (ii)	neurospheres	does	not	represent	
pure	 populations	 of	 NSCs,	 rather	 the	 minority	 of	 NSCs	 is	 subject	 to	 spontaneous	









for	 NSCs,	 the	 uniform	 access	 to	 nutrients	 provided	 by	 adherent	 cultures	 suppressed	
spontaneous	differentiation	and	cell	death,	allowing	the	expansion	of	pure	population	of	
GSCs,	 homogeneously	 expressing	 neural	 progenitor	 markers	 (Figure	 2.2A-B).	 The	
generation	of	multiple	cell	 lines	 from	distinct	 subtypes	of	gliomi,	 indicated	 that	 specific	
features	of	the	original	tumour	are	recapitulated	in	vitro.	Cell	morphology,	differentiation	
and	 invasive	 capability,	 in	 particular,	 were	 demonstrated	 to	 be	 cell	 line-specific.	 For	
instance,	while	most	of	the	GSC	lines	mainly	generate	neuronal-like	and	astroglial-like	cells	
when	 subjected	 to	 differentiation	 condition,	 a	 GSC	 line	 derived	 from	 a	 GBM	 with	
oligodendrocyte	 component,	 were	 found	 expressing	 markers	 of	 oligodendrocyte	
precursors	in	presence	of	EGF	and	bFGF,	and	mature	oligodendrocyte	upon	differentiation.	







new	 therapeutic	 options.	 Many	 studies	 focused	 on	 the	 elucidation	 of	 molecular	
mechanisms	 governing	GSC	 tumorigenic	 properties	 and	 how	 these	 ultimately	 influence	
tumour	behaviour.	Lineage	tracing	experiments	using	mouse	models	have	proved	that	a	
subpopulation	 of	 glioma	 cells	 with	 features	 of	 quiescent	 stem	 cells	 is	 responsible	 for	
tumour	recurrences	following	temozolomide-induced	initial	remission	(Chen	et	al.,	2012).	
More	 recently,	 DNA	barcoding	 has	 been	 used	 trace	 freshly	 dissociated	 cells	 from	GBM	





































21	 base	 pairs	 sequence,	 was	 identified	 in	 1992	 as	 a	 DNA	 region	 conferring	 neuronal	
specificity	 to	 the	 type	 II	 voltage-dependent	 sodium	 channel	 (Scn2a)	 expression	 in	 the	
vertebrate	nervous	system	(Kraner	et	al.,	1992).	Three	years	later,	the	protein	responsible	
for	 restricting	 Scn2a	 expression	 to	 neurons	 was	 identified	 and	 was	 named	 Repressor	
Element	1	(RE1)	Silencing	Transcription	(REST)	factor	or	Neuron	Restrictive	Silencing	Factor	
(NRSF)	 (Chong	et	al.,	1995;	Schoenherr	and	Anderson,	1995).	 In	 the	developing	mouse	
embryo,	REST	was	found	expressed	almost	ubiquitously	outside	of	the	nervous	system,	and	
particularly	 in	 those	 cell	 types	 that	 do	 not	 express	 Scn2a	 (Chong	 et	 al.,	 1995).	
Independently,	 REST	was	 detected	 in	 non-neuronal	 tissues	 and	 undifferentiated	 neural	
progenitors	and	was	indicated	as	master	negative	regulator	of	neurogenesis	following	the	
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discovery	 of	 its	 ability	 to	 selectively	 repress	 neuron-specific	 genes	 through	 RE1	
(Schoenherr	and	Anderson,	1995).	
REST	 is	 a	 Krüppel-type	 zinc	 finger	 transcription	 factor,	 a	 family	 of	 proteins	 involved	 in	















regulators	 of	 neuronal	 activity,	 and	 are	 more	 generally	 associated	 to	 cell	 metabolism,	
signalling	 pathways,	 and	 transcription	 factors.	 Interestingly,	 a	 subset	 of	 these	 genes	 is	












To	allow	wrapping	of	 the	 long	eukaryotic	 genome	 into	 the	nucleus,	DNA	 interacts	with	
histones	 in	 complexes	 knows	 as	 nucleosomes,	 that	 are	 further	 packed	 to	 form	 the	
chromatin.	The	compact	and	protective	chromatin	architecture	impedes	direct	accessibility	
by	 regulatory	 complexes	 and	 the	 transcriptional	 machinery	 so	 that	 the	 expression	 of	
inaccessible	genes	is	blocked.	Local	modifications	of	the	chromatin	structure	are	performed	
by	 chromatin-modifying	 enzymes	 to	 allow	 access	 to	 specific	 genes.	 The	 chromatin-
modifying	 enzymes	 act	 through	 either	 reversible	 post-translational	 modifications	 of	
histones,	 to	 change	 histone-DNA	 interactions	 in	 order	 to	 move,	 disrupt	 or	 assembly	
nucleosomes,	or	DNA	methylation	and	demethylation	to	regulate	direct	access	to	particular	
DNA	sequences	(Becker	and	Workman,	2013;	Jones	et	al.,	2015).	
The	 transcriptional	 repression	 activity	 exerted	 by	 REST	 is	 achieved	 through	 epigenetic	
remodelling	 of	 the	 chromatin	 landscape	 into	 a	 close	 environment,	 inaccessible	 to	 non-
pioneering	 transcription	 factors,	 i.e.	 transcription	 factors	 able	 to	 bind	 condensed	
chromatin.	 In	 order	 to	 mediate	 its	 function,	 REST	 orchestrates	 several	 chromatin	
remodelling	 enzymes	 able	 to	 remove	 modifications	 associated	 with	 active	 gene	




regions	 interact	 with	 two	 separate	 corepressor	 complexes:	 CoREST	 and	 mSin3a,	
respectively.	 REST	 functions	 therefore	 as	 a	 bridge,	 bringing	 histone	 deacetylases,	




(SMARCA4/BRG1),	 lysine-specific	 histone	 demethylase	 1A	 (KDM1A/LSD1),	 and	 the	
euchromatic	histone-lysine	N-methyltransferase	2	(EHMT2/G9a)	








3’s	 lysine	 9	 (H3K9)	 promotes	 the	 KDM1A/LSD1	 removal	 of	 histone	 3’s	 lysine	 4	 (H3K4)	
methylations	(Lee	et	al.,	2005)	and	EHMT2/G9a	dimethylation	of	H3K9	itself	(Roopra	et	al.,	
2004).	 Interestingly,	 long-term	repression	of	REST	 target	genes	can	be	accomplished	by	
stabilisation	of	the	chromatin	condensation	when	methylated	H3K9	is	bound	by	HP1	and	
recruited	by	adjacent	nucleosomes	(Lunyak	et	al.,	2002;	Roopra	et	al.,	2004;	Wood	et	al.,	
2003),	although	 it	 is	unclear	how	long	the	repression	would	 last.	 In	particular	situations	
involving	loss	of	REST,	such	as	neuronal	differentiation,	RE1-containing	genes	repression	












sites	 and	 stabilisation	 of	 the	 binding	 to	DNA	 through	 nucleosome	 repositioning	 exerted	 by	 the	
chromatin-remodelling	 enzyme	 BRG1.	 REST	 corepressors	 mSin3	 and	 CoREST	 are	 subsequently	
recruited	to	amino	and	carboxy	termini	of	REST.	B.	HDACs	deacetylate	lysine	residues	on	histones	
H3	and	H4.	H3K9	deacetylation	results	in	C.	induction	of	LSD1	activity	and	D.	H3K9	methylation	by	












The	 recruitment	 of	 different	 corepressors	 might	 produce	 the	 juxtaposition	 of	 specific	
chromatin	modifications	 resulting	 in	 both	 tissue	 specificity	 of	 REST	 targets	 and	 distinct	











RE1s	 are	 characterised	by	a	 repressive	 chromatin	 state	due	 to	H3K9	dimethylation	and	
H3K27	trimethylation	and	consistently	they	are	expressed	at	very	low	levels.	Lineage-	and	






Interestingly,	 the	 great	 majority	 of	 the	 identified	 binding	 sites	 were	 cell	 line	 specific,	
insinuating	most	of	the	REST	activity	is	cell-	or	tissue-dependent.	
The	lineage	specificity	of	REST	targets	was	further	explored	by	means	of	ChIP-sequencing	
and	 RNA-sequencing	 data	 from	 15	 cell	 lines,	 including	 self-renewing	 human	 embryonic	
stem	cells	(hESCs)	and	hESC-derived	neurons,	CD4+	T	cells	and	tumour	cell	lines	of	different	
origins.	 Only	 7%	 of	 the	 16.913	 identified	 non-redundant	 REST	 binding	 regions,	
corresponding	to	10.286	genes	and	miRNA,	presented	common	RE1s	to	all	the	cell	types	





specificity	 in	 its	 activity,	 with	 ancient	 sites	 having	more	 affinity	 for	 REST	 than	 lineage-
specific	RE1s	(Johnson	et	al.,	2009).	More	in	detail,	the	comparison	of	REST	binding	sites	in	
human	 versus	 murine	 ESCs	 suggested	 that	 the	 human-specific	 REST	 targets	 are	 more	


















depends	 on	 the	 extent	 of	 the	 DNA	 binding	 domain	 and	 results	 in	 a	 proportional	 gene	
repression	activity	(Palm	et	al.,	1999).	The	neural-specific	exon	drives	a	frameshift	in	the	






and	Hersh,	 2003).	 REST4	 has	 been	 shown	 to	 act	mainly	 as	 REST	 dominant	 negative	 by	
competing	for	RE1s	and	therefore	promoting	target	de-repression	(Raj	et	al.,	2011;	Tabuchi	
et	al.,	2002).	The	inclusion	of	the	neural	exon	seems	to	be	driven	by	the	splicing	regulator	







for	 untranslated	 exons.	 Introns	 are	 shown	 as	 lines.	 Grey	 bars	 indicate	 zinc-finger	 motifs.	 B.	
illustration	of	alternative	splicing	transcripts	of	human	REST.	Black	boxes	correspond	to	the	open	






GC	 boxes	 recruiting	 the	 Sp1	 transcription	 factors	 to	 enhance	 REST	 expression.	 All	 the	













neuronal	 differentiation,	 which	 binds	 REST	 promoter	 at	 the	 level	 of	 the	 retinoic	 acid	
receptor	element	(RARE)	located	upstream	of	the	transcription	start	site	and	thus	represses	
REST	 expression	 (Ballas	 et	 al.,	 2005).	 Finally,	 the	 presence	 of	 RE1	 sequences	 at	 REST	


















REST	 expression	 is	 also	 post-transcriptionally	 modulated,	 through	 specific	 microRNAs	
targeting	 REST	 mRNA.	 For	 example,	 miR-9,	 miR-124	 and	 miR-132	 are	 induced	 upon	
neuronal	 differentiation	 and	 target	 REST	 mRNA	 for	 degradation	 (Conaco	 et	 al.,	 2006;	
Laneve	et	al.,	2010;	Packer	et	al.,	2008;	Wu	and	Xie,	2006).	
Full-length	 REST	 has	 a	 predicted	molecular	weight	 of	 116	 kDa.	However,	many	 reports	
showed	a	higher	molecular	weight	when	REST	was	tested	in	vitro	and	for	years	researchers	
suggested	O-linked	glycosylation	(Kwon	et	al.,	2013;	Lee	et	al.,	2000,	2016;	Pance	et	al.,	
2006;	 Shimojo	 et	 al.,	 1999),	 as	 main	 cause	 of	 molecular	 weight	 increase,	 as	 already	
demonstrated	for	a	number	of	other	proteins	(Apweiler	et	al.,	1999;	Gross	et	al.,	1989;	
Selcuk	Unal	et	al.,	2008).	REST4	was	also	reported	to	be	O-glycosylated	(Lee	et	al.,	2000),	






Nuclear	 localisation	 of	 REST	 is	 directed	 by	 REST/NRSF-interacting	 LIM	 domain	 protein	
(RILP),	that	recognises	the	nuclear	localisation	signal	(NLS)	in	the	fifth	zinc-finger	domain	




inhibit	 its	 transcriptional	 repression	 on	 neuronal	 genes,	 among	 which	 Brain-derived	





ubiquitin	units	 to	or	 from	proteins	 in	order	 to	 regulate	protein	 turnover	 (Heride	et	al.,	





to	 particular	 lysine	 residues.	 Such	 tag	 can	 target	 proteins	 to	 proteasome	 degradation.	




Processes	 of	 ubiquitination	 and	 deubiquitination	 have	 been	 shown	 to	 regulate	 the	





TrCP).	 This	 event,	 leading	 to	 proteasomal	 degradation,	 causes	 the	 derepression	 of	 the	
spindle	assembly	checkpoint	associated	protein	MAD2,	avoiding	mitotic	defects	 such	as	
shortened	 mitosis,	 premature	 sister-chromatid	 segregation,	 chromosome	 bridges	 in	
anaphase	 and	 tetraploidy	 (Guardavaccaro	 et	 al.,	 2008).	 Following	 mitotic	 exit,	 non-
phosphorylated	 REST	 is	 rapidly	 replenished,	 assisted	 by	 ubiquitin	 specific	 peptidase	 15	
(USP15),	 that	 support	 its	accumulation	 from	early	G1	 to	 late	G2.	USP15	 localises	 in	 the	
cytosol	and	does	not	oppose	the	degradation	of	pre-existing	nuclear	REST,	but	it	acts	on	
newly	 synthesized,	 non-glycosylated	 120	 kDa	 REST,	 favouring	 its	 maintenance	 before	
glycosylation	mechanisms	take	part	(Faronato	et	al.,	2013).	Acting	on	a	different	binding	
motif	than	the	one	recognised	for	mitotic	checkpoint	regulation,	the	β-TrCP	also	facilitates	
REST	 degradation	 during	 neuronal	 differentiation	 (Westbrook	 et	 al.,	 2008).	 This	
mechanism	 is	 counterbalanced	by	ubiquitin	 specific	 peptidase	7	 (USP7/HAUSP),	 able	 to	
stabilise	REST	and	antagonise	β-TrCP	to	maintain	multipotency	in	neural	stem	cells	(Huang	
et	 al.,	 2011).	 Interestingly,	 both	 REST	 ubiquitination	 and	 deubiquitination	 have	 been	
associated	to	pathological	conditions.	In	particular,	β-TrCP	has	been	found	either	induced	
or	repressed	in	epithelial	and	neural	cancers,	respectively,	in	which	REST	plays	opposing	










REST	 to	ESC	 transcription	 factor	genes,	 including	Nanog,	Estrogen	related	 receptor	beta	
(Essrb)	and	Lin28,	supported	the	interaction	with	the	core	pluripotency	circuit	(Johnson	et	
al.,	 2008).	 REST	 has	 also	 been	 proposed	 to	 repress	 microRNA-21	 preventing	 it	 from	
targeting	Sox2	to	maintain	self-renewal	and	pluripotency	of	murine	ESCs	(Singh	et	al.,	2008,	
2015).	 However,	 a	 series	 of	 studies	 analysing	 ESC	 lines	 with	 a	 reduced	 or	 null	 REST	
expression,	reported	that	pluripotency	is	not	affected	by	REST	deregulation	(Buckley	et	al.,	
2009;	 Jørgensen	 and	 Fisher,	 2010;	 Jørgensen	 et	 al.,	 2009b,	 2009a;	 Singh	 et	 al.,	 2010;	















longitudinally	 to	 all	 the	 cell	 types	 in	which	REST	 is	 active.	 Even	 fully	 differentiated	 and	
mature	neurons	benefit	from	very	small	levels	of	REST	in	order	to	fine-tune	the	expression	








Figure	 3.5.	 Expression	 of	 REST	 during	 development	 and	 REST	 KO	 mice.	 A.	 Rest	 expression	
visualised	by	GFP	reporter	in	Rest	floxed/+	ESCs.	B.	Rest	floxed/+	embryo	shows	GFP	expression	in	
both	 the	 inner	 cell	 mass,	 composed	 of	 pluripotent	 stem	 cells,	 and	 the	 trophoectoderm	 at	 the	
blastocyst	 stage.	 C.	 Virtually	 ubiquitous	 REST	 expression	 in	 E14.5	 embryo	 (Aoki,	 2018).	 D.	
Comparison	of	E10.5	wild	type	and	REST	KO	embryos	(Nechiporuk	et	al.,	2016). 
 
During	 embryonic	 neurogenesis,	 REST	 appears	 to	 be	 progressively	 downregulated.	 Its	
expression	is	maximal	in	NSCs	and	declines	during	neuronal	differentiation	and	maturation	




functions.	 These	 main	 stages	 of	 neurogenesis	 can	 be	 identified	 by	 analysing	 cell	
morphology,	proliferative	capacity	as	well	as	the	expression	of	specific	markers.	REST	role	
in	 adult	 neurogenesis	 has	 been	mainly	 enlighten	 in	 the	 hippocampal	 subgranular	 zone	
(SGZ),	one	of	the	two	main	neurogenic	area	in	the	adult	mammalian	brain.	There,	qNSCs	
have	been	recognised	as	slow-dividing,	radial	cells	co-expressing	the	transcription	factor	






protein	 doublecortin	 (Dcx)	 (Gao	 et	 al.,	 2011;	Mukherjee	 et	 al.,	 2016).	 REST	 levels	 are	
maintained	 during	 the	 conversion	 from	qNSCs	 to	 TAPs,	 to	 suddenly	 fall	 in	 neuroblasts,	





that	 overtime,	 deplete	 the	 pool	 of	 qNSCs,	 thus	 determining	 the	 progressive	 loss	 of	
neurogenic	 capacity	 (Gao	 et	 al.,	 2011).	 More	 recently,	 integrating	 in	 vivo	 and	 in	 vitro	
models	 with	 ChIP-seq	 and	 RNA-seq	 techniques,	 Hsieh’s	 lab	 explored	 more	 deeply	 the	
molecular	 mechanisms	 underlying	 REST	 requirement	 in	 the	 different	 phases	 of	 adult	
neurogenesis,	 revealing	a	differential	 transcriptional	activity	controlling	 transitions	 from	
every	 maturation	 stage.	 The	 deletion	 of	 Rest	 gene	 from	 qNSCs	 revealed	 a	 selective	




target	 genes	 in	 these	 cell	 types,	 although	 this	 mechanism	might	 be	 influenced	 by	 the	






























REST	 deregulation	 is	 considered	 an	 important	 driver	 of	 neural	 tumour	 formation	 and	
epithelial	tumour	aggressiveness,	with	many	reports	proposing	it	as	prognostic	marker	for	
these	types	of	cancer	(Coulson	et	al.,	2000;	Wagoner	and	Roopra,	2012;	Wagoner	et	al.,	
2010).	 It	 is	 interesting	to	note	that	the	many	and	differential	functions	fulfilled	by	REST,	
have	generated	an	apparently	paradoxical	role	for	REST	in	cancer	biology.	Indeed,	REST	has	
been	 indicated	 as	 oncogenic	 factor	 for	 cancers	 of	 the	 nervous	 system	 while	 being	
considered	a	 tumour	 suppressor	 in	 epithelial	 neoplasia.	 This	 paradox	depicting	REST	 as	
either	hero	or	villain	depending	on	the	(cellular)	context	can	be	explained	however,	if	we	
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consider	 the	 complex	 machinery	 surrounding	 REST	 activity	 and	 how	 it	 regulates	
neurogenesis	and	cell	cycle,	as	well	as	its	more	ancient	role	as	repressor	of	neuronal	genes.	
REST	 upregulation	 in	 neural	 tissues	 results	 in	 differentiation	 failure	 and	 increased	 self-
renewal/proliferative	potential	of	progenitor	cells,	determining	abnormal	growth.	On	the	










its	 possible	 role	 in	 GBM.	 The	 telomerase-associated	 protein	 2	 (TRF2),	 which	 acts	 by	
protecting	 and	 stabilising	 telomeres	 (de	 Lange,	 2005;	Ning	 et	 al.,	 2006),	was	 shown	 to	
inhibit	REST	degradation	(Zhang	et	al.,	2008)	and	REST	was	for	the	first	time	detected	in	

















sometimes	 to	 the	 inability	 to	propagate	 the	cells	 in	 vitro,	 and	determined	an	 increased	
proportion	of	cells	expressing	the	neuronal	marker	Neuron-specific	Class	III	β-Tubulin	(β3-
tubulin)	and	a	reduction	of	those	cells	immunoreactive	for	the	neural	progenitor	markers	
Nestin	 and	Oligodendrocyte	 transcription	 factor	 2	 (OLIG2)	 (Figure	3.7A-B)	 (Conti	 et	 al.,	
2012).	These	experiments	demonstrated	that	REST	silencing	in	GSCs	results	in	the	exit	from	
cell	 cycle	 and	 the	 transition	 from	 an	 immature	 to	 a	 more	 differentiated	 phenotype.	




Most	 interestingly,	 the	 feasibility	 of	 a	 therapeutic	 application	 targeting	 GSCs	 has	 been	
demonstrated	by	direct	in	vivo	injection	of	lentiviral	particles	carrying	shRNA	anti-REST	in	
established	heterotopic	 tumours	 (Conti	et	al.,	2012).	The	comparison	of	 the	expression	
profile	of	GSCs	expressing	high	and	low	REST	also	suggested	a	possible	implication	in	the	









Caspase	 3	 were	 used	 to	 mark	 M-phase	 cells	 (actively	 proliferating	 cells)	 and	 apoptotic	 cells,	
respectively.	B.	 Quantification	 of	 the	 cells	 in	A.	C.	 Coronal	 sections	 of	 grafted	 brains	 following	
injection	 of	 control	 and	 REST	 knock-down	 hGSCs.	 Haematoxylin	 &	 eosin	 (H&E)	 staining	 shows	
















of	 the	 prognostic	 value	 of	 the	 REST	 activity,	 a	 significant	 survival	 advantage	 has	 been	




were	 almost	 absent	 in	 patients	with	 high	 REST	 activity	 (Figure	 3.8C).	 In	 an	 attempt	 to	
identify	a	possible	cause	for	REST	overactivation	in	GBM,	the	authors	analysed	the	copy	











REST	 activity	 results	 in	 a	 poorer	 prognosis	 and	 is	 characteristic	 of	 classical	 and	
mesenchymal	 molecular	 subtypes	 of	 GBM.	 Consistently,	 IDH1/2	 mutations,	 typical	 of	
proneural	 GBM	 and	 associated	 with	 a	 better	 prognosis	 (see	 chapter	 1.3	 for	 details)	
associated	with	a	decreased	REST	activity.	To	better	understand	the	impact	of	REST	activity	
on	 global	 gene	 expression	 pattern,	 the	 REST	 score	 was	 correlated	 with	 transcriptomic	
profiles	 of	 GBM	 samples	 from	 the	 cancer	 genome	 atlas	 database.	 The	 gene	 ontology	
analysis	of	the	9533	genes	significantly	associated	with	the	REST	score	included	pathways	
already	 described	 to	 affect	 brain	 tumour	 aggressiveness,	 such	 as	 cell	 adhesion	 and	
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invasion,	 cell	 proliferation,	 protein	 translation,	 and	 apoptosis.	 To	 identify	 possible	
therapeutic	options	that	take	into	consideration	REST	activity	in	GBM,	the	authors	analysed	
a	public	drug	sensitivity	database,	the	Genomics	of	Drugs	Sensitivity	in	Cancer	(Yang	et	al.,	






showing	 cells	 sensitivity	 to	 common	 chemotherapeutic	 drugs	 versus	 protein	 kinase	 inhibitors	
depending	 on	 the	 expression	 levels	 of	 a	 GBM-specific	 REST	 signature	 (Liang	 et	 al.,	 2016).	 C.	







































context-specific	 activities	 of	 REST	 are	 exerted	 through	differential	modulation	of	 target	




















of	 hGSCs	 fundamental	 properties,	 including	 their	 multipotency	 and	 tumorigenic	
competence.	In	particular,	repression	of	REST	in	hGSCs	in	vitro	results	in	a	reduction	of	cell	
self-renewal	and	migratory	ability,	accompanied	by	a	switch	from	a	multipotent	state	to	a	
differentiated	 neuronal-like	 state	 and	 an	 induction	 of	 apoptosis.	 These	 processes	
translated	into	the	eradication	of	the	hGSCs	tumorigenic	abilities	in	vivo	(Conti	et	al.,	2012;	
Kamal	 et	 al.,	 2012;	 Zhang	 et	 al.,	 2016).	 However,	 little	 is	 known	 about	 the	molecular	
mechanisms	through	which	REST	exerts	its	pathological	function	in	hGSCs.	Gene	expression	
analyses	 in	 GBM	 primary	 samples	 and	 hGSCs	 suggested	 an	 involvement	 of	 REST	 in	 a	
number	of	biological	processes	possibly	accounting	for	its	cancerous	activities	(Kamal	et	
al.,	 2012;	 Liang	 et	 al.,	 2016;	Wagoner	 and	 Roopra,	 2012),	 but	 nevertheless	 none	 has	
currently	identified	the	molecular	mediators	of	these	functions.	This	information	will	not	
only	shed	light	on	the	role	REST	in	hGSCs	but	will	also	provide	novel	exploitable	targets	for	
a	 therapy	aimed	at	 specifically	 interfere	with	hGSCs	 function(s)	and	ultimately	 reducing	
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GBM	growth	and	recurrence.	However,	 in	designing	a	strategy	 intended	to	address	 this	
question,	a	significant	factor	that	has	to	be	acknowledged	is	the	role	of	REST	in	other	cell	







In	 order	 to	 identify	 the	molecular	 network	 regulated	 by	 REST	 specifically	 in	 hGSCs,	we	
generated	 human	 GSC	 and	 NSC	 lines	 in	 which	 REST	 expression	 can	 be	 manipulated	
inducibly.	We	took	advantage	of	a	series	of	single	vector	Tet-on	systems	for	modifying	REST	
expression	 in	an	 inducible	way	already	described	 in	Meerbrey	et	al.,	2011,	 and	we	use	
them	 for	 generating	 hGSC	 and	 hNSC	 lines	 in	 which	 REST	 can	 be	 either	 silenced	 or	
overexpressed	following	administration	of	doxycycline	into	the	culture	medium.	In	order	
to	identify	the	best	vector,	we	tested	two	systems	to	mediate	REST	knock-down	(Figure	
5.1A-B)	 and	 two	 for	 REST	 overexpression	 (Figure	 5.1C-D)	 along	 with	 their	 relative	




ii. a	 reporter	gene	 for	 infection	 (enhanced	green	 fluorescent	protein,	eGFP)	or	an	
antibiotic	resistance	cassette	(puromycin	resistance,	Puro,	or	neomycin	resistance,	
Neo)	
iii. an	 inducible	 region	 where	 tetracycline	 responsive	 element	 (TRE)	 controls	 the	































days	 after	 infection,	 fluorescence	 imaging	 revealed	 the	presence	of	 eGFP+	 cells	 in	 both	
pIND11	(55%	eGFP+	cells/total	cells)	and	pIND11shREST	(87%	eGFP+	cells/total	cells)	hGSC	
cultures,	 indicating	 the	effective	expression	of	 the	 constitutive	 region	of	 the	 constructs	




5.1A,	 lower	 section).	 After	 48	 hours	 of	 doxycycline	 induction,	 cultures	were	 lysed	 and	
processed	 for	RNA	extraction.	We	 then	performed	a	quantitative	 reverse	 transcription-
polymerase	chain	reaction	(qRT-PCR)	to	evaluate	REST	modulation	in	the	cultures.	Control	
hGSCs	 infected	 with	 pIND11	 showed	 no	 variation	 in	 REST	 transcript	 levels	 following	
doxycycline	 treatment,	 while	 the	 expression	 of	 the	 shRNA	 anti-REST	 (shREST)	 in	 the	
pIND11shREST	hGSCs	resulted	in	a	40%	reduction	of	REST	mRNA	(0.58	±	0.08	folds	with	
respect	 to	 untreated	 pIND11shREST	 hGSCs,	 Figure	 5.1B).	 Expression	 analysis	 of	 known	
REST	targets	revealed	an	induction	of	synaptosome	associated	protein	25	(SNAP25,	5.78	±	
0.75	folds)	and	brain-derived	neurotrophic	factor	(BDNF,	1.53	±	0.03	folds),	suggesting	a	
de-repression	 of	 REST-modulated	 genes	 (Figure	 5.1C).	 These	 results	 indicate	 that	 a	
reduction	of	 REST	mRNA	 levels	 occurs	 in	 doxycycline-treated	pIND11shREST	hGSCs	 and	
that	 doxycycline	 treatment	 does	 not	 affect	 REST	 levels	 in	 control	 pIND11	 hGSCs.	
Furthermore,	the	de-repression	of	some	of	the	REST	target	genes	in	doxycycline-treated	



























of	 the	 cultures	 revealed	 no	 evident	 changes,	 suggesting	 the	 absence	 of	 unspecific	
doxycycline-induced	 effects,	 even	 at	 the	 highest	 concentration	 used	 (Figure	 5.2A).	
Interestingly,	 we	 found	 that	 tRFP	 expression	 was	 dependent	 on	 the	 concentration	 of	
doxycycline	as	we	could	observe	a	proportional	increase	in	both	the	number	of	tRFP+	cells	
as	 well	 as	 the	 intensity	 of	 the	 fluorescent	 signal	 depending	 on	 the	 concentration	 of	
doxycycline	 (Figure	 5.2A).	 These	 results	 suggest	 a	 dose-dependent	 expression	 of	 the	
inducible	 region	 of	 the	 pINDUCER	 system	 that	 may	 result	 in	 different	 levels	 of	 REST	
silencing.	We	performed	a	qRT-PCR	assay	in	order	to	evaluate	whether	REST	knock-down	
is	also	dependent	on	the	concentration	of	doxycycline	in	the	medium.	As	shown	in	figure	
5.2B,	 pIND11	 hGSCs	 reported	 a	 small,	 not	 significant,	 variation	 in	 REST	 mRNA	 levels	
between	different	doxycycline	doses	and	anyway	not	proportional	to	the	concentration	of	
doxycycline.	 Vice	 versa,	 the	 pIND11shREST	 hGSCs	 treated	 with	 increasing	 doses	 of	
doxycycline	 exhibited	 a	 dose-response	 silencing	 of	 REST,	 reaching	 a	 maximum	 of	 40%	
repression	 (0.60	 ±	 0.04	 folds	with	 respect	 to	 untreated	pIND11shREST	hGSCs)	with	 the	
highest	concentration	of	doxycycline	considered	(Figure	5.2B).	The	dose-response	effect	
was	 also	 observed	 in	 the	 de-repression	 of	 REST	 target	 genes,	 proportional	 to	 the	
concentration	of	doxycycline	used	(Figure	5.2C).	These	results	highlight	one	more	time	the	
specificity	of	the	pINDUCER11shREST	system	in	the	downregulation	of	REST,	but	also	show	
that	REST	expression	 is	 tunable	depending	on	 the	experimental	variation	of	 the	culture	
conditions	(i.e.	doxycycline	dose).	Since	none	of	the	concentration	of	doxycycline	tested	






Figure	 5.2.	 Doxycycline	 dose	 selection	 in	 pIND11	 GSCs	 and	 pIND11shREST	 hGSCs.	 A.	
Representative	pictures	of	pIND11	hGSCs	and	pIND11shREST	hGSCs	treated	with	different	doses	of	
doxycycline	 for	 48	 hours.	 eGFP	 expression	 indicates	 infected	 cells,	 tRFP	 expression	 indicates	
activation	of	the	Tet-on	system.	Scale	bar:	200	μm.	B.	qRT-PCR	assay	for	REST	expression.	C.	qRT-
PCR	 assay	 for	 REST	 target	 genes	 expression.	 qRT-PCR	 quantifications	 have	 been	 normalised	 on	




Another	 parameter	 influencing	 shRNA	 expression	 in	 Tet-on	 systems	 is	 the	 timing	 of	
induction	of	the	transgene.	In	order	to	verify	whether	we	can	enhance	the	degree	of	REST	
knock-down	 in	 pIND11shREST	 hGSCs	 by	 playing	 with	 the	 timing	 of	 treatment,	 we	
performed	 a	 time	 course	 experiment	 in	 which	 the	 cells	 were	 treated	 with	 the	 same	
concentration	of	doxycycline	(500	ng/ml)	for	different	time,	and	we	analysed	the	relative	
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mRNAs	 amount	 of	 REST	 and	 SNAP25	 as	 representative	 of	 REST-target	 modulation	 at	
different	time	points	(Figure	5.3).	During	the	five	days	of	experiment,	we	could	observe	the	
pIND11	hGSCs	growing	at	 an	apparent	normal	 rate,	 indicating	a	prolonged	exposure	 to	
doxycycline	did	not	hamper	cell	cycle	(Figure	5.3A).	Also,	looking	at	the	intensification	of	





observed	over	 time	 is	 due	 to	 an	 accumulation	of	 the	 fluorescent	 protein	 leading	 to	 an	
increased	signal	rather	than	a	time-dependent	induction	of	the	TRE-regulated	transgenes.	






























of	 pIND11	 hGSCs,	 in	 this	 case	 we	 collected	 cells	 with	 medium-to-high	 eGFP	 signal,	



















hours	 of	 induction,	 we	 decided	 to	 focus	 on	 these	 short	 time	 points.	 Live	 cell	 imaging	
showed	a	more	homogeneous	eGFP	signal	between	cells,	along	with	a	general	increase	in	
its	intensity	with	respect	to	unsorted	cells,	confirming	the	results	obtained	from	the	flow	
cytometry	analysis	post-sorting	 (Figure	5.5A).	 The	qRT-PCR	analysis	 showed	 that	 sorted	
high	eGFP+	pIND11shREST	hGSCs	not	only	 retained	 the	REST	knock-down	ability,	but	as	
expected,	their	silencing	efficiency	is	improved	as	REST	mRNA	was	reduced	to	0.52	±	0.06	
folds	 at	 24	hours	 and	0.64	±	 0.09	 folds	 at	 48	hours	of	 treatment	with	doxycycline.	We	






hGSCs	 in	 an	 inducible	 way.	 In	 addition,	 either	 by	 using	 different	 concentration	 of	
doxycycline	or	considering	different	time	points,	it	is	possible	to	tune	REST	knock-down	to	
different	 extents.	 However,	 a	 significant	 question	 mark	 remains	 because	 of	 the	
heterogeneous	 intensity	 of	 the	 eGFP	 fluorescence	 within	 shREST	 and	 control	 cell	
populations,	even	after	the	selection	through	cell	sorting.	This	variability	possibly	reflects	





















selection	 led	 to	 the	 generation	 of	 control	 pIND10	 and	 pIND10shREST	 hGSCs.	 To	 verify	






(Figure	 5.6A).	 Real-time	 PCR	 analysis	 revealed	 that	 levels	 of	 REST	 transcript	 in	
pIND10shREST	 hGSCs	 decremented	 to	 0.58	 ±	 0.04	 folds	 at	 48	 hours	 of	 doxycycline	
induction.	At	protein	level,	we	measured	a	91%	decrease	in	REST	expression	(0.09	folds)	
that	caused	a	de-repression	of	SNAP25	and	synaptophysin	(SYP)	transcripts	by	6.53	±	0.26	















expression	 at	 48h.	 qRT-PCR	 and	 immunoblotting	 quantifications	 have	 been	 normalised	 on	
untreated	 cells	 at	 the	 corresponding	 time	 point.	 Results	 are	 expressed	 as	 mean	 ±	 standard	
deviation	and	statistical	significance	inferred	using	t-test. 
ns:	non-statistically	significant;	***:	p	<	0.001;	****:	p	<	0.0001. 












































































0.04	and	0.80	±	0.04	 folds	 at	 24	and	48	hours,	 respectively	 (Figure	5.7C).	 Interestingly,	














μm.	 B.	 Representative	 picture	 of	 western	 blot	 analysis	 for	 REST	 and	 relative	 densitometric	
quantification.	C.	qRT-PCR	assay	for	REST	expression.	D.	qRT-PCR	assay	for	the	REST	target	gene	
(SNAP25)	 expression.	 qRT-PCR	 and	 immunoblotting	 quantifications	 have	 been	 normalised	 on	









hGSCs	 has	 been	 associated	 to	 the	 regulation	 of	 cell	 proliferation,	 differentiation	 and	










As	 initial	 analysis,	 we	 performed	 a	 cell	 proliferation	 assay	 by	 means	 of	 the	 3-(4,5-























induction	 of	 neuronal	 differentiation	 and	 loss	 of	 multipotency.	 In	 order	 to	 investigate	
whether	such	phenotype	occurs	 in	our	hNSCs	and	hGSCs	 lines,	we	tested	whether	REST	
knock-down	can	be	maintained	for	long	time	in	vitro.	We	initially	analysed	REST	expression	
by	means	of	 immunocytochemistry	 in	 long-term	 induced	(ten	days)	REST	KD	hNSCs	and	
hGSCs.	 CTRL	 hNSCs	 and	 hGSCs	 did	 not	 shown	 any	 significant	 effect	 on	 REST	
immunoreactive	signal,	both	in	term	of	intensity	and	localization,	further	proving	that	non-
targeting	shRNAs	do	not	alter	cell	properties/behaviour	(data	not	shown).	On	the	contrary,	
we	 observed	 a	 remarkable	 downregulation	 in	 the	 intensity	 of	 REST	 immunoreactivity	




















REST	 knock-down	 (data	 not	 shown).	 Conversely,	 REST	 silencing	 strongly	 affected	 Sox2	
expression	 in	hGSCs,	as	demonstrated	by	 the	 loss	of	Sox2	 immunoreactive	signal	 in	 the	
doxycycline-treated	 cells	 (Figure	 5.10A-B,	 43.27	 ±	 4.97%	doxy	versus	 89.94	 ±	 0.99%	no	




impairs	 hGSCs	 multipotency,	 even	 though	 it	 is	 not	 enough	 for	 the	 cells	 to	 completely	
differentiate,	as	shown	by	the	maintenance	of	Nestin	expression.	The	trend	of	hNSCs	to	
lose	 Sox2	 immunoreactivity	 following	 silencing	 of	 REST,	 indicates	 a	 similar	 yet	 smaller	
sensitivity	 to	 REST	 loss,	with	 respect	 to	 the	 behaviour	 observed	 in	 hGSCs.	 In	 the	 same	


















cells	 in	 REST	 KD	 hGSC	 cultures.	 C.	 Quantification	 of	 Sox2+	 cells	 in	 REST	 KD	 hNSC	 cultures.	
Quantification	is	normalised	on	untreated	cells	and	expressed	as	%	of	immunoreactive	cells	on	total	








Figure	 5.11.	 REST	 knock-down	 induces	 neuronal	 differentiation	 in	 both	 hGSCs	 and	 hNSCs.	A.	














Finally,	 we	 analysed	 the	 occurrence	 of	 apoptosis	 in	 the	 cultures	 by	 means	 of	 cleaved	
caspase	 3	 expression	 in	 REST	 KD	 hNSC	 and	 hGSC	 cultures	 treated	 with	 or	 without	
doxycycline	for	ten	days.	Immunofluorescence	analysis	highlighted	an	increased	number	of	
cleaved	 caspase	 3	 immunoreactive	 hGSCs	 following	 REST	 knock-down	 (Figure	 5.12A-B	
246.97	±	45.40%	doxy	versus	100.00	±	28.76%	no	doxy),	while	no	significant	effect	was	






pictures	of	 immunofluorescence	assay	 for	 cleaved	caspase	3	performed	on	REST	KD	hGSCs	 (left	
panels)	and	REST	KD	hNSCs	(right	panels)	treated	with	500	ng/ml	doxycycline	for	ten	days.	Scale	





















with	 the	 neomycin	 analogue	 G418.	 Once	 selected,	 we	 tested	 the	 performance	 of	 the	
cultures	in	terms	of	REST	overexpression	levels.	To	this	end,	an	initial	pilot	experiment	was	
performed	 inducing	 cells	 with	 the	 conditions	 previously	 described	 for	 REST	 KD	 lines.	
Effective	induction	was	assessed	by	analysing	the	relative	REST	mRNA	levels	and	a	selection	
of	REST	target	genes.	Quantitative	RT-PCR	assay	showed	a	high	and	specific	induction	of	
REST	 transcript	 levels	 only	 upon	addition	of	 doxycycline	 in	 pIND20hREST	hGSCs	 (Figure	




in	 altering	REST	 transcription	 (Figure	6.1A).	 Contrary	 to	what	observed	when	REST	was	
silenced,	the	overexpression	of	REST	did	not	cause	any	modulation	of	SNAP25	mRNA	levels.	
However,	both	VGF	and	TUBB3	were	significantly	repressed	in	REST	overexpressing	cells,	



















experiment	 of	 induction.	 Since	 the	 excess	 of	 REST	 is	 usually	 managed	 by	 the	 cell	 via	
ubiquitination	 and	 proteasome	 degradation	 (Guardavaccaro	 et	 al.,	 2008;	 Huang	 et	 al.,	
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2011;	Singh	et	al.,	2011;	Westbrook	et	al.,	2008),	we	treated	the	cells	with	the	proteasome	
inhibitor	MG-132,	 in	 order	 to	maximize	 the	 amount	 of	 REST	 following	 induction.	Upon	
doxycycline	 treatment,	 pIND20hREST	 hGSCs	 exhibited	 an	 apparent	 light	 reduction	 in	
proliferation	without	anyway	showing	any	appreciable	morphological	change	during	the	
course	of	 the	experiment	 (Figure	6.2A).	As	observed	 in	 the	pilot	experiment,	REST	was	
successfully	and	highly	overexpressed	selectively	in	the	induced	pIND20hREST	hGSCs,	while	
pIND20	hGSCs	did	not	show	any	modulation	in	REST	levels	(Figure	6.2B).	Overexpression	








increase	 at	 24	 hours,	 14.61	 folds	 at	 48,	 and	 6.00	 folds	 at	 72	 hours	 (Figure	 6.2D).	 As	
expected,	 the	proteasome	 inhibitor	MG-132	was	able	 to	 counteract	 the	degradation	of	
REST,	 increasing	 the	doxycycline-induced	overexpression	by	six	 folds	at	48	hours	 (85.48	
folds)	and	two	folds	at	72	hours	(11.94	folds)	of	induction.	Little	variation	in	REST	protein	
was	observed	also	 in	 the	 control	pIND20	hGSCs,	 especially	when	 treated	with	MG-132,	
however	with	a	lower	degree	than	pIND20hREST	cultures	(Figure	6.2D).	This	is	attributable	








hours.	 Scale	bar:	200	μm.	B.	qRT-PCR	assay	 for	REST	expression.	C.	qRT-PCR	assay	 for	 the	REST	
target	gene	VGF	expression.	D.	Representative	picture	of	western	blot	analysis	for	REST	and	relative	
densitometric	quantification.	qRT-PCR	and	immunoblotting	quantifications	have	been	normalised	




In	 parallel	 with	 pIND20hREST	 hGSCs,	 in	 order	 to	 select	 the	 best	 system	 for	 REST	
overexpression	we	generated	also	pIND22hREST	hGSCs	and	 the	 relative	control	pIND22	
hGSC	 line.	 This	 system	 differs	 from	 pINDUCER20hREST	 since	 the	 Neomycin	 resistance	
cassette	is	replaced	by	an	eGFP	cassette,	thus	allowing	live	recognition	of	transduced	cells	




cells	 by	 FACS	 analysis	 reported	 that	 only	 2.6%	 of	 the	 pIND22	 hGSCs	 and	 12.8%	 of	 the	
pIND22hREST	 hGSCs	 were	 eGFP+	 (Figure	 6.3B-C	 before	 sorting),	 thus	 confirming	 our	
qualitative	observations.	To	increase	the	number	of	infected	cells	in	the	two	populations,	
we	selected	eGFP+	cells	by	means	of	cell	sorting.	In	this	way,	we	managed	to	increase	the	







treatment,	 we	 observed	 a	 24.18	 ±	 1.65	 folds	 and	 27.06	 ±	 4.49	 folds	 increase	 in	
pIND22hREST	hGSCs	at	24	and	48	hours,	 respectively	 (Figure	6.4B).	No	effects	on	REST	
mRNA	levels	were	visible	in	doxycycline-treated	pIND22	hGSCs	(Figure	6.4B).	Importantly,	
the	observed	 raising	 in	REST	 transcript	 levels	 resulted	 in	an	 increased	 repression	of	 the	
REST	target	gene	VGF	(Figure	6.4C,	fold	change	with	respect	to	non-induced	pIND22hREST	
hGSCs:	0.39	±	0.02	at	24	hours,	and	0.25	±	0.03	at	48	hours),	indicative	of	a	higher	REST	
transcriptional	 repression	 activity.	 Also,	 following	 doxycycline	 treatment,	 REST	 protein	
levels	were	found	increased	exclusively	in	pIND22hREST	hGSC	line	(Figure	6.4D,	fold	change	
with	respect	to	non-induced	pIND22hREST	hGSCs:	2.73	at	24	hours	and	8.32	at	48),	though	


















hours.	 Scale	bar:	200	μm.	B.	qRT-PCR	assay	 for	REST	expression.	C.	qRT-PCR	assay	 for	 the	REST	
target	gene	VGF	expression.	D.	Representative	picture	of	western	blot	analysis	for	REST	and	relative	
densitometric	quantification.	qRT-PCR	and	immunoblotting	quantifications	have	been	normalised	










doxycycline	 for	 24	 hours	 and	 assaying	 by	 qRT-PCR	 the	 expression	 levels	 of	 REST	 and	 a	
selection	 of	 REST	 target	 genes	 (Figure	 6.5).	 Interestingly,	 REST-overexpressing	 hNSCs	
showed	 a	 reduction	 of	 cell	 proliferation	 similar	 to	 what	 previously	 observed	 in	
pIND20hREST	hGSCs	 (data	not	shown),	 though	 they	also	presented	evident	signs	of	cell	
detachment	with	respect	to	untreated	pIND20hREST	hNSCs	and	pIND20	hNSCs,	possibly	
due	to	the	repression	of	many	adhesion	molecules	known	to	be	controlled	by	REST	(Figure	
6.5A,	 Sun	 et	 al.,	 2005,	 2008;	 Johnson	 et	 al.,	 2006;	 Otto	 et	 al.,	 2007).	 Cultures	 of	
pIND20hREST	hNSC	showed	a	marked	 increase	of	REST	mRNA	(Figure	6.5B,	 fold	change	
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6.3	Effect	of	REST	gain	of	function	on	hGSCs	and	hNSCs	properties	






































hGSCs	 and	 hNSCs	 in	 presence	 of	 doxycycline.	We	 initially	 analysed	 REST	 expression	 by	
means	of	immunocytochemistry	in	long-term	induced	(ten	days)	CTRL	and	REST	OE	hGSCs	
and	 hNSCs.	 We	 found	 that	 REST	 immunoreactivity	 increased	 dramatically	 in	 both	
doxycycline-treated	REST	OE	hGSC	and	hNSC	cells	 (Figure	6.7).	Analysis	of	NSC	markers,	








GFAP+	 cells	 occurred	 (fold	 of	 increase	 of	 GFAP+	 hNSCs:	 5.42;	 fold	 of	 increase	 of	 GFAP+	
hGSCs:	6.98)	in	REST-overexpressing	hGSCs	and	hNSCs	(Figure	6.9C	and	F).	Interestingly,	

































































































































hNSCs.	 A.	 Representative	 pictures	 of	 immunofluorescence	 for	 Nestin	 and	 GFAP	 expression	
performed	on	REST	OE	hGSCs	(upper	panels)	and	REST	OE	hNSCs	(lower	panels)	treated	with	500	
ng/ml	doxycycline	for	ten	days.	Scale	bar:	100	μm.	B.	Quantification	of	Nestin+	cells	in	REST	OE	hGSC	
cultures.	 C.	 Quantification	 of	 GFAP+	 cells	 (%)	 in	 REST	 OE	 hGSC	 cultures.	 D.	 Quantification	 of	
Nestin+/GFAP+	cells	in	REST	OE	hGSCs.	E.	Quantification	of	Nestin+	cells	in	REST	OE	hNSC	cultures.	
F.	Quantification	of	GFAP+	cells	in	REST	OE	hNSC.	G.	Quantification	of	Nestin+/GFAP+	cells	in	REST	












































































































OE	 hGSCs	 and	 hNSCs	 with	 the	 corresponding	 untreated	 control	 cells	 (Table	 7.2,	
comparisons	 2,	 3,	 6,	 and	 7).	 Finally,	 tumour	 and	non-pathological	 REST-specific	 targets	
were	identified	intersecting	the	differentially	expressed	genes	in	REST-modulated	hGSCs	
with	those	whose	expression	changes	in	REST-modulated	hNSCs	(Table	7.2,	comparison	9).	








































without	 anyway	 affecting	 cells’	 survival	 and	 growth.	 REST	 OE	 hGSCs	 and	 hNSCs	 were	
treated	 for	 24	 hours,	 the	 earliest	 time	 points	 to	 achieve	 REST	 protein	 overexpression	
following	 doxycycline	 treatment	 (Figure	 6.2D	 and	 6.5D),	 accompanied	 by	 an	 increased	
repression	of	REST	target	genes	(Figure	6.2C	and	6.5C).	Effective	REST	silencing	appeared	
slower	 than	 overexpression,	 probably	 because	 it	 is	 achieved	 through	 a	 more	 complex	
mechanism	 with	 doxycycline	 driving	 the	 transcription	 of	 shRNAs	 anti-REST	 that	 are	




RNAs	 from	 the	 samples	 listed	 in	 table	 7.1	 were	 retro-transcribed	 and	 hybridised	 on	
microarray	chips,	passing	the	quality	control	tests	for	sample’s	reliability,	and	the	data	were	




a	 segregation	 into	 two	major	 clusters,	 composed	 selectively	 by	 either	 hGSCs	 or	 hNSCs,	
independently	 from	 REST	 modulation	 (Figure	 7.1).	 Within	 the	 two	 macro-groups,	 the	
second	layer	of	clustering	is	composed	according	to	the	level	of	REST	expression,	with	REST-
overexpressing	 cells	 clustering	 separately	 from	REST-silencing	 cells	 and	 separately	 from	
untreated/parental	samples.	
Differentially	 expressed	 transcripts	 in	 doxycycline	 treated	 versus	 control	 were	 selected	
with	a	false	discovery	rate	(FDR)	<	0.05.	Using	this	criterion,	we	obtained	550	(among	which	
532	downregulated)	and	150	(among	which	145	downregulated)	differentially	expressed	




(Appendix	 B).	 Surprisingly,	 only	 9	 coding	 transcripts	 (all	 of	 them	 upregulated)	 resulted	
differentially	expressed	in	REST	KD	hNSCs	versus	control	cells	(Appendix	D).	This	result	was	
unexpected	given	our	previous	molecular	and	phenotypic	characterisation	of	the	cells	and	
the	 literature	 data,	 suggesting	 REST	 downregulation	 deeply	 impact	 hNSCs	 biology.	
Moreover,	before	sending	RNA	samples	for	microarray	analysis	we	tested	REST	and	REST	
target	genes	modulation	by	qRT-PCR	obtaining	results	comparable	to	the	ones	presented	
in	 figure	 5.7C	 and	 D	 (data	 not	 shown).	 Comparison	 of	 parental	 untreated	 cells	 versus	
parental	 cells	 cultured	 in	 presence	 of	 doxycycline	 identified	 differentially	 expressed	
transcripts	 whose	 regulation	 is	 affected	 by	 doxycycline	 treatment.	 These	 genes	 were	
subsequently	subtracted	by	the	list	derived	from	the	comparison	of	REST	OE	or	REST	KD	
hGSCs	 and	 hNSCs	 with	 the	 respective	 untreated	 cell	 lines.	 Among	 the	 466	 genes	 (201	
coding	genes)	modulated	by	doxycycline	in	hGSCs,	none	was	shared	with	either	induced	

















Human Neural Stem Cells Human Glioma Stem Cells
REST OE – Doxy
REST KD – Doxy
REST OE – No doxy
Parental – No doxy
Parental – Doxy
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7.2	 REST	 controls	 neural	 multipotency	 through	 modulation	 of	 neuronal	 differentiation,	
proliferation	and	cell	metabolism	





neural	 cell	 projection,	 membrane	 potential	 and	 synaptic	 transmission,	 and	 embryonic	
development	processes	(Figure	7.2-7.4).	Among	all	of	the	pathways	controlling	the	stem	
cell	behaviour,	Wnt	was	the	single	over-represented	in	REST	OE	hGSCs	and	hNSCs	(Figure	
7.2	 and	 7.4).	 Interestingly,	 both	 hGSCs	 and	 hNSCs	 network	 are	 enriched	 in	 processes	
related	 to	 cell	 metabolism	 and	 oxidative	 stress	 (Figure	 7.2-7.4	 and	 7.5),	 suggesting	 a	
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We	 then	 analysed	 gene	ontology	 processes	 in	 REST	OE	hGSCs	 and	hNSCs	 and	REST	 KD	
hGSCs	and	divided	them	according	to	the	direction	of	gene	deregulation	upon	modulation	
of	REST	 (Figure	7.5).	Respect	 to	GSEA,	 this	analysis	better	highlighted	 the	different	 role	
REST	covers	in	hGSCs	and	hNSCs,	as	well	as	the	changes	in	gene	expression	happening	soon	
after	overexpression	and	silencing	of	REST	 in	hGSCs.	For	 instance,	the	most	significantly	
deregulated	 process	 in	 REST	 OE	 hNSCs	 is	R-HAS-112315:	 Transmission	 across	 Chemical	
Synapses,	that	also	represent	also	the	only	neuronal-related	process	in	hNSCs,	while	the	








hGSCs	 and	 hNSCs	 identified	 modifications	 in	 cell-cell	 interaction	 manifested	 by	 cells	
growing	closer	to	each	other	in	both	doxycycline-treated	REST	OE	hGSCs	and	hNSCs	respect	
to	 untreated	 cultures.	 However,	 it	 is	 interesting	 to	 note	 that	 only	 hGSCs	 showed	 an	
enrichment	 of	 such	 processes.	 Genes	 associated	 to	 circadian	 rhythm	 and	 lipid-steroid	





acid-,	 cholesterol-,	 fatty	acids-,	 glucidic-,	 nucleotides-,	nitrogen-	metabolism,	autophagy	
and	 oxidative	 phosphorylation,	 as	 well	 as	 transcription	 factors	 master	 regulators	 of	
energetic	 metabolism	 and	 mitochondrial	 biogenesis	 (e.g.	 NR1D1	 and	 PPARGC1A).	
Interestingly,	almost	the	totality	of	the	identified	genes	appeared	downregulated	following	

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































To	 better	 investigate	 REST	 potential	 roles	 in	 these	 process,	 we	 took	 advantage	 of	
Integrated	 System	 for	 Motif	 Activity	 Response	 Analysis	 (ISMARA)	 to	 look	 for	 key	
transcription	factors	(TFs)	predicted	to	have	a	differential	activity	in	REST	OE	hGSCs.	We	




























ATF4/CREB2 upregulated ASCL1 achaete-scute	family	bHLH	transcription	factor	1 -1,32
EOMES/TBR2 upregulated PTCH1 patched	1 -1,15
GRHL1 upregulated HHIP hedgehog	interacting	protein -1,24
HES1 upregulated NR1D1 nuclear	receptor	subfamily	1	group	D	member	1 1,35
KLF15 upregulated FABP7 fatty	acid	binding	protein	7 -1,08
ZBTB4 upregulated SCD stearoyl-CoA	desaturase -1,14
INSM1 downregulated SQLE squalene	epoxidase -1,11


























In	 order	 to	 identify	 the	molecular	 network	 specifically	 regulated	 by	 REST	 in	 hGSCs,	we	
selected	the	differentially-regulated	genes	 that	are	both	repressed	 in	REST	OE	cells	and	
upregulated	 in	 REST	 KD	 cells	 as	 potential	 direct	 REST	 targets,	 and	 we	 crossed	 the	 list	
derived	from	hGSCs	with	the	one	derived	from	hNSCs	(Figure	7.8	and	comparison	9	in	table	
7.2).	 Unexpectedly,	 none	 of	 the	 REST	 targets	 in	 the	 hNSCs	 list	 is	 shared	 with	 hGSCs,	
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suggesting	that	even	though	the	two	cell	types	present	very	similar	features	and	some	of	














Investigating	 the	 hGSC-specific	 REST-regulated	 genes	 for	 the	 presence	 of	 common	
transcription	 factor	binding	sites,	we	 found	13	out	of	16	genes	potentially	 regulated	by	
NeuroD	 (table	 7.4),	 a	 REST	 target,	 basic	 helix	 loop	 helix	 transcription	 factor,	 known	 to	














were	 confirmed	 as	 hGSC-specific	 and	 regulated	 according	 to	 the	 expression	 of	 REST.	
Indeed,	they	were	found	more	repressed	following	REST	overexpression	and	de-repressed	
after	REST	knock-down.	Also,	the	transcriptional	regulation	of	these	genes	did	not	appear	













ANKS1B ankyrin	repeat	and	sterile	alpha	motif	domain	containing	1B 2,96 -2,05 yes yes
CKMT1A creatine	kinase,	mitochondrial	1A 8,19 -3,92 yes yes
CKMT1B creatine	kinase,	mitochondrial	1B 8,41 -2,41 yes yes
DRD2 dopamine	receptor	D2 6,63 -4,59 yes yes
ELAVL4 ELAV	like	RNA	binding	protein	4 10,94 -3,23 yes yes
PPARGC1A PPARG	coactivator	1	alpha 9,12 -3,17 yes no
AGT angiotensinogen 3,88 -3,02 no yes
CADPS2 calcium	dependent	secretion	activator	2 4,61 -2,4 no no
CAMKV CaM	kinase	like	vesicle	associated	 2,6 -2,35 no yes
CNRIP1 cannabinoid	receptor	interacting	protein	1 3,25 -2,9 no yes
DUSP15 dual	specificity	phosphatase	15 3,61 -2,37 no yes
GABBR2 gamma-aminobutyric	acid	type	B	receptor	subunit	2 2,64 -2,97 no yes
HHIP hedgehog	interacting	protein 3,69 -3,41 no no
NFASC neurofascin 2,73 -5,63 no yes
NOS2 nitric	oxide	synthase	2 2,93 -4,31 no yes


































shREST REST	OE shREST REST	OE
AGT 1.01 ± 0.05 2.00 ± 0.03 5.3 ± 0.52 0.4 ± 0.03
ANKS1B 0.55 ± 0.02 0.52 ± 0.12 1.79 ± 0.04 0.37 ± 0.07
CADPS2 0.09 ± 0.03 0.86 ± 0.58 5.73 ± 1.46 0.65 ± 0.34
CAMKV 1.21 ± 0.12 1.16 ± 0.09 2.3 ± 0.04 0.56 ± 0.12
CKMT1A/B 2.26 ± 0.04 0.3 ± 0.05 4.83 ± 0.12 0.37 ± 0.24
CNRIP1 1.04 ± 0.08 0.31 ± 0.05 3.16 ± 0.37 0.25 ± 0.09
DRD2 1.27 ± 0.06 2.39 ± 0.46 1.92 ± 0.05 0.6 ± 0.04
DUSP15 1.16 ± 0.09 0.42 ± 0.11 3.88 ± 1.32 0.11 ± 0.07
ELAVL4 0.57 ± 0.24 1.78 ± 0.25 6.07 ± 0.22 0.79 ± 0.52
GABBR2 1.71 ± 0.03 0.84 ± 0.03 2.28 ± 0.47 0.52 ± 0.06
HHIP 0.78 ± 0.08 0.56 ± 0.04 3.69 ± 1.54 0.16 ± 0.02
NFASC 1.52 ± 0.11 1.46 ± 0.03 3.08 ± 0.14 0.2 ± 0.00
NOS2 1.09 ± 0.36 0.85 ± 0.01 1.59 ± 0.14 0.55 ± 0.04
PDGFRA 0.85 ± 0.51 1.13 ± 0.22 1.41 ± 0.19 0.67 ± 0.08



























Figure	 7.10.	 Prognostic	 potential	 of	 the	 hGSC	 REST	 score.	 A.	 Correlation	 between	 REST	 gene	
expression	and	the	hGSC	REST	score	in	the	TCGA	cohort,	r	=	-0.46	and	p	<	0.0001.	B.	Correlation	
between	 the	 hGSC	 REST	 score	 and	 OS	 of	 GBM	 patients	 from	 the	 TCGA	 cohort.	 C.	 Correlation	
between	 the	 hGSC	 REST	 score	 and	 PFS	 of	 GBM	 patients	 from	 the	 TCGA	 cohort.	D.	 Correlation	






























the	 tumour	 bulk,	 and	 few	 slow-cycling	 CSCs	 as	 main	 driver	 of	 tumour	 growth,	
chemoresistance,	and	relapses.		
Understanding	 the	 biology	 of	 GSCs	 is	 the	 key	 to	 disclose	 new	 and	 effective	 targeted	




signalling	 pathways	 regulating	 their	 behaviour.	 The	 CSC	 peculiarities	 manifest	 more	
explicitly	when	they	are	orthotopically	xenotransplanted	in	experimental	animal	models:	
while	ASCs	differentiate	into	tissue	derivatives	and	integrate	with	the	resident	cells	(e.g.	





Communal	 ASCs	 and	 CSCs	 signalling	 pathways	 are	 involved	 in	 controlling	 cells’	




















maintenance	 of	multipotency	 in	 neural	 progenitors	 and	 hGSCs	 (Basu-Roy	 et	 al.,	 2015;	
Favaro	et	al.,	2014;	Mao	et	al.,	2015;	Pevny	and	Nicolis,	2010)	and	its	levels	were	shown	
to	 correlate	 to	 those	 of	 REST	 in	 hGSCs	 (Kamal	 et	 al.,	 2012).	 Also,	 importantly	 to	 GBM	
patients’	 survival,	 a	 lower	Sox2	expression	 is	 generally	 associated	 to	a	better	prognosis	





abnormally	 upregulated,	 coexpressed	 with	 Nestin	 and	 GFAP,	 and	 proposed	 it	 as	
pharmacological	target	(Katsetos	et	al.,	2011).	Moreover,	β3-tubulin	in	other	tumours	has	
been	 shown	 to	play	major	 role	 in	 chemoresistance	and	 cellular	 adaptation	 to	oxidative	
stress	 (Cicchillitti	et	al.,	2008;	De	Donato	et	al.,	2012;	Gan	et	al.,	2007).	 It	 is	 therefore	
possible,	that	although	not	contributing	to	tumour	growth,	β3-tubulin	does	sustain	survival	
of	differentiated	tumour	cells.	
We	also	confirmed	 that	 loss	of	REST	causes	a	 reduction	 in	 self-renewing	ability	of	both	
hGSCs	and	hNSCs	(Figure	5.8),	an	event	required	for	NSCs	to	acquire	a	neuronal	phenotype.	
These	results	 indicate	 that	despite	 the	culture	conditions	were	selected	 for	suppressing	
differentiation	and	maintaining	hGSCs	and	hNSCs	in	a	self-renewing	and	multipotent	state,	
loss	of	REST	function	induces	a	neuronal-like	differentiation.	This	might	be	associated	to	




effect	 in	 hNSCs	 (Figure	 5.12).	 Caspase	 3	 represents	 the	 meeting	 point	 between	 the	








previously	 described	 roles	 of	 REST	 on	 proliferation,	 differentiation	 and	 apoptosis.	
Interestingly,	the	comparison	between	the	two	cell	types	revealed	a	palpable	difference	in	









Upon	 long-term	 REST	 overexpression,	 we	 found	 an	 increased	 Sox2	 immunoreactivity,	
indicating	that	the	cells	maintained	a	multipotent	and	tumorigenic	phenotype	(Figure	6.8).	
This	 condition	 was	 also	 characterised	 by	 an	 increased	 number	 of	 cells	 exhibiting	 the	
coexpression	of	GFAP	and	Nestin,	that	typically	mark	quiescent	adult	NSCs.	In	GBM,	besides	
being	used	as	differentiation	marker,	GFAP	role	is	largely	unclear.	It	has	been	proposed	to	
be	 downregulated	 due	 to	 promoter	 methylation	 and	 that	 its	 expression	 negatively	
correlates	with	GBM	histological	malignancy	 (Hara	 et	 al.,	 1991;	 Restrepo	 et	 al.,	 2011).	
However,	GFAP	appears	expressed	 in	a	subset	of	Sox2	and	Nestin-expressing	GBM	cells	
exhibiting	 increased	 tumorigenic	 ability	 in	 vivo	 with	 respect	 to	 GFAP-/Sox2-	 cells	
(Hägerstrand	et	al.,	2011).	hGSCs	express	variable	levels	of	GFAP	depending	on	the	GBM	












performed	a	gene	ontology	analysis	on	REST	modulated	 cells.	Our	 results	 showed	 that,	
even	 though	 very	 few	 genes	 are	 communal	 between	 hGSCs	 and	 hNSCs,	 most	 of	 the	
biological	 processes	 regulated	 in	 these	 cells	 are	 shared.	 Indeed,	 we	 found	 REST	 to	 be	











Our	 gene	 ontology	 analysis	 on	 REST-modulated	 cells	 also	 highlighted	 a	 previously	
undescribed	 regulation	 of	 cell	 metabolism	 in	 both	 hGSCs	 and	 hNSCs	 (Figure	 7.2-7.4).	
Indeed,	 along	 with	 terms	 associated	 to	 neuronal	 differentiation	 and	 function	 that	 are	
present	in	both	REST	OE	and	REST	KD	hGSCs,	genes	regulating	lipid	and	steroid	metabolism,	
cell	adhesion	and	migration,	and	response	to	hypoxia	were	found	deregulated	in	REST	OE	
hGSCs	 (Figure	 7.5B-B’),	 while	 REST	 knock-down	 in	 hGSCs	 causes	 deregulation	 of	 genes	
involved	 in	 cell	 death,	 cell-matrix	 interaction,	 gluconeogenesis,	 PPARα	 signalling	 and	
circadian	rhythms	(Figure	7.5A-A’).	A	number	of	genes	associated	to	circadian	rhythm	have	










is	able	 to	directly	 repress	 the	circadian	 regulator	Clock,	 leading	 to	 impairments	 in	GBM	
cells’	proliferative	and	migratory	ability	(Li	et	al.,	2013).	Since	cell	metabolism	and	circadian	
rhythm	are	deeply	interconnected,	and	both	have	been	shown	to	influence	NSC	quiescence	













of	 transcription	 factors	previously	 reported	to	 regulate	 the	 transition	 from	quiescent	 to	
activated	NSCs	(Table	7.5	right,	Shin	et	al.,	2015).	These	transcription	factors	were	shown	
to	 regulate	 processes	 that	 in	 GBM	 or	 hNSCs	 include	 protein	 translation	 and	 cell	 cycle	
(ATF4/CREB2),	multipotency	and	differentiation	(KLF15,	NR2E1/TLX,	INSM1,	NFIA,	SOX9),	
expression	of	quiescent	NSCs	markers	(NR2E1/TLX),	and	are	part	of,	or	interact	with,	other	














- Sonic	Hedgehog	pathway	effectors:	 Patched1	 (PTCH1)	 and	hedgehog	 interacting	
protein	(HHIP)	are	two	inhibitors	of	the	SHh	signalling,	which	long	term	activation	



























gliomagenesis	 and	may	 therefore	 represent	 a	 potential	 target	 for	GBM	 care.	However,	
unless	suitable	for	local	applications,	the	use	of	anti-REST	drugs	might	harbour	substantial	
side	effects	due	to	activity	in	undesired	cell	types.	Antagonising	REST	activity	in	the	brain	
would	 potentially	 reduce	 GBM	 growth,	 as	 already	 demonstrated	 in	 pre-clinical	 studies	
using	animal	models	(Conti	et	al.,	2012;	Kamal	et	al.,	2012;	Marisetty	et	al.,	2017),	yet	also	
affect	the	NSC	compartment	behaviour.	A	strategy	to	deal	with	these	off-target	effects	is	
represented	 by	 directly	 targeting	 disease-specific	 effectors	 of	 multipotency-associated	






such	 as	 neural	 differentiation	 (ELAVL4,	 CNRIP1,	 DUSP15),	 as	 well	 as	 hNSCs	 and	 hGSCs	





2013).	We	were	 surprised	 to	 find	 genes	 involved	 in	 cell	 metabolism	 since	 this	 kind	 of	
process	has	never	been	associated	to	REST,	although	extensively	reported	to	impact	NSC	







Lange	 et	 al.,	 2016;	 Stoll	 et	 al.,	 2015;	 Xie	 et	 al.,	 2016).	 Indeed,	 the	 inhibition	 of	
mitochondrial	 metabolism	 in	 NSCs	 determines	 the	 induction	 glycolytic	 processes	 to	
support	cell	survival,	but	also	 leads	to	abnormal	cell	proliferation	and	the	acquisition	of	
tumorigenic	properties	 (Bartesaghi	et	al.,	2015).	 In	 tumours	however,	 it	 is	 still	debated	
whether	CSCs	mainly	rely	on	glycolysis	or	oxidative	phosphorylation	and	cases	of	metabolic	
switch	have	been	described	(Peiris-Pagès	et	al.,	2016).	
Interestingly,	 only	 six	 of	 the	 hGSC-specific	 REST-regulated	 genes	 identified	 in	 our	 study	
have	a	RE1	motifs	in	the	promoter	region,	suggesting	they	are	potential	direct	targets	of	
REST.	These	include:	






target	of	REST	 in	murine	 cells	 (Sun	et	al.,	 2005)	 that	mediates	 the	 tumorigenic	
potential	of	PRRX1	in	hGSCs	(PRRX1	fold-change	in	REST	OE	hGSCs:	-2.73,	Li	et	al.,	
2017).	In	GBM,	it	is	upregulated	specifically	in	respect	to	surrounding	normal	brain	
tissue,	 in	which	 it	would	stimulates	EGFR	signalling	by	 inhibiting	Rap1-GTP.	The	
combined	inhibition	of	dopamine	receptors	and	EGFR	signalling	was	also	found	to	
promote	survival	in	experimental	animal	models	of	GBM	(Li	et	al.,	2014).	
iii. Peroxisome	 proliferator-activated	 receptor	 gamma,	 coactivator	 1	 alpha	
(PPARGC1A)	encoding	for	PGC1α,	a	master	regulator	of	mitochondrial	biogenesis	










brain	 enriched	 protein	 involved	 in	 several	 neural	 disorders	 for	 its	 ability	 to	






REST	 are	 differentially	 regulated	 in	 hGSCs	 versus	 hNSCs.	 Many	 factors	 could	 influence	
target	 selectivity	 of	 REST	 transcriptional	 repression	 in	 distinct	 cell	 types,	 such	 as	 the	
availability	of	different	cofactors,	the	interplay	with	other	transcription	factors	regulating	
the	expression	of	RE1-containing	genes,	as	well	as	the	chromatin	landscape.	Our	validation	
by	 qRT-PCR	 confirmed	 that,	 among	 the	 RE1-containing	 genes,	 DRD2,	 PPARGC1A,	 and	
ANKS1B	are	selectively	regulated	by	REST	in	hGSCs	in	a	canonical	fashion,	i.e.	derepressed	
in	 REST	 KD	 cells	 and	 repressed	 in	 REST	OE	 cells.	 For	 instance,	PPARGC1A	 is	 effectively	
repressed	by	REST	in	hGSCs	and	hNSCs,	but	it	is	de-repressed	only	in	REST	KD	hGSCs,	while	
its	 expression	 does	 not	 change	 in	 REST	 KD	 hNSCs.	 One	 possibility	 is	 that	 PPARGC1A	
represents	 a	 Class	 II	 target	 as	 proposed	 by	 Ballas	 et	 al.,	 2005,	 so	 that	 even	 upon	
downregulation	 of	 REST,	 the	 repression	 is	 maintained	 by	 its	 cofactors.	 Also,	 other	














and	 Rosenfeld,	 2005;	Martin	 et	 al.,	 2015;	 Schoenherr	 and	 Anderson,	 1995).	 A	 similar	





Interestingly,	 the	 list	of	hGSCs	REST	 targets	also	 includes	platelet-derived	growth	 factor	
receptor	A	(PDGFRA),	which	gene	has	already	been	confirmed	as	target	of	REST	in	murine	
cells	(with	a	RE1	site	located	at	40	kb	from	5’,	Sun	et	al.,	2005),	and	is	frequently	amplified	















an	 inverse	correlation	with	REST	expression	 in	GBM	patients,	 indicative	of	an	 increased	
transcriptional	repression	in	presence	of	REST	(Figure	7.10A	and	E).	Even	if	the	hGSCs	REST	
score	has	been	obtained	from	the	analysis	of	a	minor	subpopulation	of	cells	in	the	tumour	
bulk,	 i.e.	 the	 hGSCs,	 these	 genes	 behave	 similarly	 in	 gene	 expression	 experiments	
performed	on	gliomi	as	a	whole,	suggesting	the	signature	we	identified	might	be	applied	in	
	 120	
clinical	 analyses	 on	 tumour	 specimens.	 The	 hGSCs	 REST	 score	 has	 been	 tested	 for	 its	
prognostic	potential	in	two	independent	cohorts	of	patients	(Figure	7.10).	REST	showed	an	
inverse	correlation	with	the	gliomi	WHO	grade,	exhibiting	a	lower	activity	(high	hGSCs	REST	
score)	 in	healthy	 individuals	and	a	progressively	higher	activity	 from	WHO	grade	2	 to	4	
(Figure	7.10F),	suggesting	that	REST	transcriptional	repression	is	generally	 lower	 in	non-
pathological	human	brain	and	increases	gradually	according	to	glioma	aggressiveness.	We	



















Wagoner	 and	 Roopra,	 2012).	 Differently	 from	 our	 hGSCs	 REST	 score	 however,	 the	
previously	published	REST	signatures	were	also	shown	to	correlate	with	patients’	OS.	This	
might	be	due	to	the	distinct	derivation	of	the	biological	samples	in	our	study.	
This	 is	 the	 first	 time	 that	 a	 REST	 signature	 is	 derived	 from	 hGSCs	 and	 shown	 to	 have	
potential	prognostic	relevance.	Also,	given	the	patients’	gene	expression	data	were	derived	
from	GBM	specimens	without	discerning	between	tumour	cell	subpopulations,	this	result	








Basal	 levels	 of	 REST	 have	 been	 shown	 to	 sustain	multipotency	 and	 self-renewal,	 while	
blocking	differentiation	both	in	hGSCs	and	hNSCs.	Thus,	manipulating	REST	levels	can	lead	
to	substantial	alterations	in	these	events.	Indeed,	silencing	of	REST	stimulates	neuronal	(-
like)	 differentiation	 both	 in	 hGSCs	 and	 hNSCs,	 while	 increased	 REST	 levels	 results	 in	
preservation	of	multipotency	in	these	cell	types,	and	has	been	shown	to	induce	a	quiescent	
status	in	adult	murine	NSCs.	Our	results	suggest	that	REST	ability	to	drive	quiescence	might	
























differential	 role	 exerted	 by	 REST	 in	 hGSCs	 respect	 to	 hNSCs	 and	 to	 validate	 the	 hGSC-
specific	REST-regulated	genes	before	a	clinical	approach	is	ventured.	For	instance:	
Does	REST	actually	 regulate	 cell	metabolism	 in	 hNSCs	and	hGSCs?	A	 set	 of	 biochemical	
analyses	on	cell	metabolism	should	be	performed	to	identify	whether	the	transcriptomic	
modifications	 observed	 in	 silico	 reflects	 biological	 variation	 in	 cell	 metabolism	 and	
behaviour.		
Does	REST	truly	induce	quiescence	in	hGSCs?	To	this	aim,	a	deeper	investigation	of	REST	OE	








and	 widen	 it	 to	 atypical	 RE1s	 potentially	 involved	 in	 regulating	 hGSC-specific	 REST-
regulated	genes	expression.	Chromatin	 immunoprecipitation	(ChIP)	should	then	validate	
the	actual	binding	of	REST	to	hGSC-specific	REST-regulated	genes	in	hGSCs.	
How	 does	 REST	 choses	 different	 targets	 in	 hGSCs	 and	 hNSCs?	Differential	 binding	 of	 a	
particular	transcription	factor	in	different	cell	types	might	be	influenced	by	motif	variations	
at	REST	binding	sites,	and	expression	of	REST	cofactors.	ChIP-sequencing	could	be	exploited	




GBM	 clinical	 course?	 This	 point	 should	 be	 addressed	 with	 gain	 and	 loss	 of	 function	
approaches	 for	 the	 modulation	 of	 every	 hGSC-specific	 REST-regulated	 gene	 in	 hGSCs	
followed	by	phenotypical	analyses	on	cells’	behaviour	in	vitro	and	tumorigenic	competence	
in	 vivo.	 These	 set	 of	 experiments	will	 clarify	whether	 the	 hGSC-specific	 REST-regulated	
genes	are	actual	therapeutic	targets	for	GBM.	
































GB7	cells,	 in	 this	manuscript	named	hGSCs,	were	derived	 in	by	Professor	 Luciano	Conti	





1	minute	with	StemPro	Accutase	 (Thermo	Fisher	 Scientific).	 Single	 cells	 suspension	was	
then	diluted	in	conditioned	medium	and	spun	down	at	260g	for	3	minutes	before	being	
	 126	
resuspended	 in	 fresh	medium	 and	 plated	 onto	 the	 coated	 vessels.	 hGSCs	 self-renewal	
medium	 is	 composed	of	 Euromed-N	medium	 (Euroclone),	N2	 Supplement	 (1%,	 Thermo	









for	 3	minutes	 before	 being	 resuspended	 in	 fresh	medium	 and	 plated	 onto	 the	 coated	
vessels.	hNSCs	self-renewal	medium	is	composed	of	DMEM/F-12	(Thermo	Fisher	Scientific),	































and	5	μg	of	VSV-G.	Two	days	 from	the	 transfection,	 the	supernatant	was	collected	and	







Isabella	 Pesce	 of	 the	 CIBIO	 Cell	 Analysis	 and	 Separation	 Core	 Facility	 (CASCF).	 EGFP+	
fluorescent	pIND11	hGSCs,	pIND11shREST	hGSCs,	pIND22	hGSCs,	and	pIND22hREST	hGSCs	
were	isolated	using	a	FACS	Aria	II	(Becton	Dickinson)	in	the	purity	precision	mode	with	a	













The	 real-time	 quantitative	 polymerase	 chain	 reaction	 (qRT-PCR)	was	 carried	 out	
using	the	SSO	Advanced	Universal	SyBR	Green	Supermix	kit	(Biorad)	and	the	Biorad	














saline	 solution	 for	 30	minutes	 at	 room	 temperature	 as	 suggested	 in	Lee	and	Kamitani,	













Cells	were	 fixed	with	 4%	paraformaldehyde	 for	 15	minutes	 at	 room	 temperature,	 then	
permeabilised	 with	 permeabilisation	 buffer	 for	 15	 minutes	 at	 room	 temperature	 and	
blocked	 with	 blocking	 buffer	 for	 2	 hours,	 before	 incubating	 them	 with	 the	 primary	






phosphate	 buffered	 saline;	 blocking	 buffer	 contains	 5%	 FBS/0.3%	 Triton	 X-100	 in	
phosphate	 buffered	 saline;	 antibody	 solution	 is	 made	 of	 3%	 FBS/0.2%	 Triton	 X-100	 in	
phosphate	buffered	saline.	For	quantifying	immunopositive	cells	for	the	indicated	antigen	

















Microarray	 and	 bioinformatics	 analyses	 were	 performed	 in	 collaboration	 with	 Prof.	
Giuseppe	 Basso,	 Dr.	 Silvia	 Bresolin	 and	 Dr.	 Luca	 Persano	 of	 the	 Laboratory	 of	 Onco-
Hematology,	Dept.	of	Women’s	and	Children’s	Health,	University	of	Padova,	Padova,	Italy.		
For	 microarray	 experiments,	 biological	 triplicates	 of	 hNSCs/hGSCs	 REST	 OE	 and	
hNSCs/hGSCs	 REST	 KD	 were	 treated	 for	 24	 and	 48	 hours	 respectively	 with	 500	 ng/ml	
doxycycline.	RNA	was	extracted	according	to	the	common	Tri	procedure	and	analysed	using	
Eukaryote	Total	RNA	Nano	2100	bioanalyzer	(Agilent)	for	their	quality.	RNA	with	a	RIN	>	9.5	
were	 considered	 for	 the	 experiments.	 In	 vitro	 transcription,	 hybridization	 and	 biotin	
labelling	were	performed	according	to	Human	Clariom	D	Assay	(Thermofisher,	Waltham,	
MA,	 USA).	 CEL	 files	 were	 generated	 using	 Expression	 Console	 Suite	 Software	 and	
normalized	with	RMA	(www.r-projects.org)	and	Transcriptome	Analysis	Console	Software	
(TAC	 v.4.0.0.25).	 Unsupervised	 analysis	 was	 performed	 using	 hierarchical	 clustering	
analysis	with	Ward.2	method	and	Euclidian	distance	using	probes	with	variance	more	than	
90%.	All	 transcription	clusters	(TC)	were	divided	and	analysed	separately	based	on	their	
mapping	 in	 coding	 or	 non-coding	 genes.	 Differentially	 expressed	 genes	were	 identified	
using	Significance	Analysis	of	Microarray	algorithm	coded	in	the	samr	R	package	(Tusher	et	
al.,	2001).	 In	SAM,	we	estimated	the	percentage	of	 false	positive	predictions	 (i.e.,	False	
Discovery	 Rate,	 FDR)	 with	 100	 permutations.	 	 TC	 with	 FDR<0.05	 were	 considered	
significant.	
For	coding	regions,	Gene	Set	Enrichment	Analysis	(GSEA)	was	performed	using	GSEAv2.0	





Minimum	 gene	 set	 size	 was	 set	 to	 15.	 For	 GSEA	 an	 FDR	 cutoff	 <	 0.25	 was	 used.	









on	 differentially	 significant	 TC	 (Tripathi	 et	 al.,	 2015).	 Enriched	 terms	 (GO/KEGG	 terms,	
canonical	pathways,	hall	mark	gene	sets),	hypergeometric	p-value	and	enrichment	factors	
















To	 computationally	 predicted	 regulatory	 sites	 for	 transcription	 factors	 (TFs)	 and	micro-
RNAs	 (miRNAs)	 in	doxy	 vs	no	doxy	 in	both	hNSCs	and	hGSCs	we	used	 ISMARA	analysis	
	 132	
according	to	default	parameters	(Balwierz	et	al.,	2014).	For	each	motif	inferred	activities	
across	 the	 input	 samples,	 predicted	 genome-wide	 targets,	 enriched	 pathways	 and	
functional	classes	of	genes,	and	direct	interactions	between	regulators	were	reported.	








was	 assessed	 for	 normality	 using	 the	 Shapiro-Wilk	 test.	 To	 determine	 statistical	
significance,	we	used	the	unpaired	t-test	or,	for	multiple	comparisons,	a	one-way	analysis	

















































































Ascl-1 Santa	Cruz sc-390794 1:100
β3-Tubulin Promega G712A 1:1000
Cleaved	Caspase	3	 Cell	Signaling 9661s 1:500
GFAP DAKO Z0334 1:1000
Ki67 ABCAM ab15580 1:1000
Nestin RD	System MAB1259 1:300
REST Millipore 07-579 1:1000 1:300
Sox2 Millipore AB5603 1:1000
α-Tubulin Santa	Cruz sc-53646 1:1000
Anti	Mouse	IgG	AlexaFluor	488 Molecular	Probes A11001 1:500
Anti	Mouse	IgG	AlexaFluor	568 Molecular	Probes A11004 1:500
Anti	Rabbit	IgG	AlexaFluor	488 Molecular	Probes A11008 1:500
Anti	Rabbit	IgG	AlexaFluor	568 Molecular	Probes A11011 1:500
Immun-Star	goat	anti-mouse	(GAM)-HRP Biorad 1705047 1:2000
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Affects Human Neural Stem Cells’ Behavior
Jacopo Zasso, Mastad Ahmed, Alessandro Cutarelli, and Luciano Conti
Converging evidence suggest that levels of alpha-synuclein (aSyn) expression play a critical role in Parkinson’s
disease (PD). Several mutations of the SNCA gene, encoding for aSyn have been associated to either the
familial or the sporadic forms of PD. Nonetheless, the mechanism underlying wild-type aSyn-mediated neu-
rotoxicity in neuronal cells as well as its specific driving role in PD pathogenesis has yet to be fully clarified. In
this view, the development of proper in vitro cellular systems is a crucial step. In this study, we present a novel
human Tet-on human neural stem cell (hNSC) line, in which aSyn timing and level of expression can be tightly
experimentally tuned. Induction of aSyn in self-renewing hNSCs leads to progressive formation of aSyn
aggregates and impairs their proliferation and cell survival. Furthermore, aSyn induction during the neuronal
differentiation process results in reduced neuronal differentiation and increased number of astrocytes and
undifferentiated cells in culture. Finally, acute aSyn induction in hNSC-derived dopaminergic neuronal cultures
results in cell toxicity. This novel conditional in vitro cell model system may be a valuable tool for dissecting of
aSyn pathogenic effects in hNSCs and neurons and in developing new potential therapeutic strategies.
Keywords: alpha-synuclein, human neural stem cells, Parkinson’s disease, neurons, inducible expression
Introduction
Lewy bodies (LBs) are considered a capital hallmark ofParkinson’s disease (PD). They consist of cytoplasmic
inclusions mainly composed of fibrillar misfolded alpha-
synuclein (aSyn) aggregates within the brain parenchyma [1].
aSyn is a small 140-residue protein highly abundant in neurons
and particularly localized at the presynaptic terminals, where it
is thought to play roles in vesicle trafficking and in the assem-
bling of the SNARE complex for neurotransmitter release [2].
Mutations of the SNCA gene, encoding for aSyn, are either
associated to rare familial PD or represent risk factors for
sporadic PD [3,4]. Furthermore, increased SCNA copy number
variation has been shown to be causal for PD, thus suggesting
that increased aSyn protein levels are sufficient to trigger
the disease [5]. In PD patients, aggregation of aSyn in LBs
has been shown, resulting in its mislocalization and loss of
function, ultimately leading to the loss of dopaminergic
neurons. Besides its role in mature neurons, in vivo aSyn
overexpression has been shown to affect proliferative po-
tential of mouse hippocampal neural stem cells (NSCs),
resulting in a reduction of the pool of neural progenitors
and decreased neuronal differentiation and maturation [6–9].
Also, ectopic expression of aSyn was shown to affect the
migration of NSCs in mouse subventricular zone [10].
Despite the association to PD has been known for de-
cades, aSyn function in human neural stem cells (hNSCs)
and neurons as well as its involvement in PD are still poorly
understood. So far, the main limitations have been due to the
inaccessibility of adequate in vitro cellular models. Indeed,
most of the studies aimed at defining a clear role for aSyn in
normal and PD neurons have been so far carried out using
either non-human systems, including rodent culture [6,7,10],
non-neuronal transformed cell lines [11], or noncentral
nervous system (CNS)-derived neuronal-like cells [12,13].
More recently, the advent of human-induced pluripotent
stem cells (hiPSCs)’ technology has widened opportunities
to model human conditions, including the possibility to
generate bona fide hNSCs and mature neurons and conse-
quently matching the affected cells in neurodegenerative
disorders [14]. hiPSC lines derived from PD patients car-
rying triplication of the SNCA locus have been reported [15].
These cells were proven to efficiently differentiate and mature
into TH+ve dopaminergic neurons while showing a twofold
increase in aSyn protein levels with respect to hiPSCs derived
from unaffected relatives and recapitulating some aspects of
the patient physiology. Interestingly, neuronal precursor cells
derived from these PD hiPSCs have been reported to exhibit
significant deficiencies in growth, viability, cellular energy
metabolism, and stress resistance [16], thus indicating that
aSyn may play important roles in hNSC physiology.
Similarly, wild-type (wt) aSyn overexpression in fetal
cortex-derived hNSCs has been shown to impair cell growth
and neuronal versus glial lineage commitment [17]. Finally,
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aSyn overexpression has been described to reduce the
number of mouse secondary neurospheres formed and to
affect NSC morphology and cell cycle progression, leading
to their accelerated differentiation [10]. These studies sug-
gest that there is a link between neurogenesis, aSyn, and
neurodegenerative diseases [18].
In this study, we report the generation of a novel in vitro
cell system in which levels and timing of human wt aSyn
expression can be experimentally tightly controlled in
hiPSC-derived long-term expandable NSCs. Following in-
duction, a progressive increase of aSyn levels can be
achieved, leading to the formation of aSyn cytoplasmic
aggregates. This versatile system allows to investigate the
effects of aSyn expression on hNSCs behavior, including
self-renewal and differentiation programs.
Our results show that induction of aSyn leads to a re-
duction in hNSCs growth accompanied by an increased
susceptibility to apoptosis. During neuronal differentiation
process, aSyn induction affects neurogenic potential and
induces an increase in the number of astrocytes and undif-
ferentiated cells in culture. Furthermore, acute aSyn induc-
tion resulted in enhanced apoptotic cell death in hNSC-
derived dopaminergic neurons.
This novel in vitro cell system may represent a valuable
tool for studying aSyn-driven pathogenic-relevant mecha-




AF22 cells (kindly donated by Prof. Austin Smith, Cam-
bridge Stem Cell Institute, University of Cambridge, UK)
were previously described [19]. Cells were routinely pas-
saged every 2–3 days at a density of 2.5–3.5 · 104 cells/cm2
in hNSCs Self-renewal medium composed of Dulbecco’s
modified Eagle’s medium/Nutrient Mixture F-12 (DMEM/
F-12; Thermo Fisher Scientific), N2 supplement (1%; Thermo
Fisher Scientific), B27 supplement (1%; Thermo Fisher Sci-
entific), EGF (10 ng/mL; PeproTech), bFGF (10 ng/mL; Pe-
proTech), and GlutaMAX (2 mM; Thermo Fisher Scientific).
Briefly, before seeding the cells, plastic culture vessels were
treated with 3mg/mL Laminin (Thermo Fisher Scientific) at
37!C for 3–5 h. For passaging, cells were incubated for 1–
2 min with StemPro Accutase (Thermo Fisher Scientific) and
centrifuged at 260 g for 3 min. Pellet was resuspended in fresh
medium and plated onto the laminin-coated vessels.
For general neuronal differentiation, cells were seeded on
laminin-coated cell culture-grade plasticware at a density of
8 · 103 cells/cm2 in self-renewal medium. The following
day, medium was shifted to self-renewal medium deprived
of EGF and bFGF. After 3 additional days, medium was
replaced with neuronal differentiation medium composed of
a 1:1 mix of Neurobasal (Thermo Fisher Scientific), and
DMEM/F-12, N2 supplement 1%, B27 supplement 1%,
cAMP 300 ng/mL, and GlutaMAX. For aSyn induction
during differentiation process, a medium supplemented with
doxycycline was replaced every 24 h.
For dopaminergic neuronal differentiation, self-renewing
cultures were maintained in the presence of 200 ng/mL of
both FGF8 and SHH for 2–3 weeks to specify a ventral
midbrain dopaminergic fate, before differentiating them as
in the general neuronal differentiation. Seven hundred and
fifty nanograms per milliliter of doxycycline were added at
21 days in vitro (DIV) every 24 h for 4 DIV before fixing the
cells for immunocytochemistry.
Lentiviral particle preparation and AF22 cell
infection
Lentiviral particles carrying the pLVX-TetOne-Puro-
human aSyn vector (kindly donated by Dr. Tilo Kunath,
University of Edinburgh, UK) were prepared. This vector,
based on the pLVX-TetOn-Puro plasmid (Clontech) is
specifically designed to carry on a single vector the com-
plementary DNA (cDNA) for a tetracycline transactivator
(Tet-on 3G) and a tetracycline responsive promoter (TREGS
promoter) containing seven tetracycline-responsive ele-
ments (TRE) controlling the expression of the cDNA for
human aSyn. The vector also carries a puromycin resistance
cassette for selection of infected cells.
For lentiviral particle preparation, 6 · 104 HEK 293T
cells/cm2 were seeded in DMEM containing 10% fetal bo-
vine serum (FBS) and left undisturbed overnight. The fol-
lowing day, cells were transfected by CaPO4 method with
20mg of pLVX-TetOne-Puro-human aSyn, 15mg of psPAX2
vector (kindly provided by Prof. M. Pizzato, University of
Trento, Italy), and 5mg of VSV-G. Two days after transfec-
tion, the supernatant was collected and concentrated using the
Lenti-X concentrator reagent (Clontech) following the man-
ufacturer’s recommendation.
For AF22 cell infection, 10 mL of concentrated lentiviral
particles were used to infect 2 · 104 cells/cm2. After 8 h, the
medium was completely changed, and 72 h later, positive
selection of the transduced cells was started with 0.3 mg/mL
puromycin (Thermo Fisher Scientific) until the noninfected
control cells died completely. Cultures were subsequently
selected with higher doses of puromycin as discussed in the
Results section.
Cell growth assay
For growth assay, 2 · 103 cells/cm2 were seeded onto
laminin-coated 24-well plates. aSyn induction was achieved
by treatment with 750 ng/mL doxycycline added to the
cultures and the medium was renewed every day. Cells were
fixed at specific time points by using 4% paraformaldehyde
for 15 min at room temperature (RT) and then nuclei were
stained with Hoechst 33258 (Thermo Fisher Scientific). Cell
counting was performed using Operetta High-Content Ima-
ging System (PerkinElmer). Images were collected with a
10· long working distance objective considering technical
quadruplicate for each time point and the cell number was
determined using the software Harmony 4.1 (PerkinElmer)
by the segmentation of the nuclear region.
Immunocytochemistry and evaluation of aSyn
aggregates
For immunofluorescence assay, cells were fixed with 4%
paraformaldehyde for 15 min at RT, then permeabilized
with 0.5% Triton X-100 in phosphate-buffered saline (PBS)
for 15 min at RT and blocked with a blocking solution (5%
FBS, 0.3% Triton X-100 in PBS) for 2 h at RT. Cultures
were then incubated over-night at 4!C with specific primary



















































antibodies (Supplementary Table S1; Supplementary Data
are available online at www.liebertpub.com/scd) diluted in a
blocking solution. After three rinses with PBS, cells were
incubated with the appropriate secondary antibodies (Sup-
plementary Table S1) for 2 h and nuclei counterstained with
Hoechst 33258 before imaging with a Leica DMIL inverted
fluorescent microscope. For the quantification of specific
immunopositive cells, at least 3,000 cells per condition for
every antigen were counted. Data were normalized on the
total number of cells in every field.
For evaluation of aSyn aggregation, cells were treated
with 750 ng/mL of doxycycline for 12 days. Cultures were
fixed with 4% paraformaldehyde for 15 min at RT and
stained with anti-aSyn antibody. Nuclei and cytoplasm were
counterstained using Hoechst 33258 and CellMask Deep
Red (Molecular Probes). Cells were analyzed using the
Operetta High-Content Imaging System. Images were col-
lected using a 20· long WD objective considering technical
quadruplicate and analyzed with Harmony 4.1 software.
Briefly, cells were identified by the segmentation of the
nuclear region based on the Hoechst 33258 signal and cy-
toplasm region of interest (ROI) was defined based on the
CellMask signal. aSyn aggregates were detected as fluo-
rescent spots inside the ROI. Number of objects, area, and
intensity of the signal were calculated for each well and
normalized on the number of aSynlow/Med- and aSynhigh-
intensity aSyn immunoreactive cells.
For the quantitative evaluation of the effect of aSyn in-
duction on mitochondrial number, cells were treated with
750 ng/mL of doxycycline for 5 days, before fixing with 4%
paraformaldehyde for 15 min at RT and stained with Mito-
tracker (Molecular Probes) to image mitochondria as re-
commended by the manufacturer. Nuclei and cytoplasm
were counterstained using Hoechst 33258 and CellMask
Deep Red (Molecular Probes). Cells were analyzed using
the Operetta High-Content Imaging System. Images were
collected and analyzed as described above. Briefly, cells
were identified by the segmentation of the nuclear region
based on the Hoechst 33258 signal and cytoplasm. ROI was
defined based on the CellMask signal. Mitochondria were
detected as fluorescent spots inside the ROI. Area and
number of objects were calculated for each well and nor-
malized on the number of cells.
Western blot analysis
Cells were lysed using the sodium dodecyl sulfate (SDS)
sample buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS, 10%
Glycerol, 50 mM DTT) and boiled for 5 min at 95!C before
loading into a 15% polyacrylamide gel run at 15 mA. After
transfer on PVDF membrane at 100 V constant for 2 h,
proteins were incubated in 0.4% paraformaldehyde in PBS
solution for 30 min at RT as previously reported [20] and
then in blocking solution (10% milk) in TBS-T for 1 h.
Membranes were further incubated O/N at 4!C in agitation
with primary antibody. After the washing step with TBS-T,
membranes were incubated with the secondary antibody for
2 h. Both primary and secondary antibodies were prepared in
TBS-T supplemented with 5% non-fat milk diluted in TBS-
T. Signal was detected using Clarity ECL reagents (Bio-
Rad) in a dark chamber Uvitec Alliance (Uvitec) and the
manufacturer software to acquire and analyze the data.
Statistical analysis
Statistical significance was assayed using a two-sided
unpaired Student’s t-test or two-way analysis of variance
with Bonferroni post hoc test using the GraphPad Prism
software. Data distribution was assessed for normality using
the Shapiro–Wilk test. P < 0.05 was considered statistically
significant.
Results
Modulation of wt aSyn expression in AF22 Tet-On
aSyn cells
To generate a hNSC line for the inducible expression of
wt aSyn, hiPSC-derived AF22 cells were infected with
lentiviral particles carrying the pLVX-TetOn-Puro-human
aSyn vector. Following infection, cultures were exposed to
1 mg/mL puromycin, chosen as optimal puromycin dose that
allows for effective selection without altering the normal
self-renewal potential of the resistant cells (Supplementary
Fig. S1A). AF22 Tet-On aSyn cells selected with this pu-
romycin dose exhibited low aSyn basal expression levels
that increased 7.7-fold following treatment with doxycycline
for 72 h (Supplementary Fig. S1B). Based on our previous
experience with Tet-On systems, the abovementioned in-
duction experiments were performed using a 750 ng/mL
dose of doxycycline.
To test if AF22 Tet-On aSyn cells show a dose-dependent
level of induction and to test at which dose of doxycycline it
reached the maximum level of induction, we treated the cul-
tures for 72 h with different concentrations of doxycycline (0,
100, 250, 500, 750, and 1,000 ng/mL). A clear dose-response
relationship in the induction of aSyn expression levels was
found, reaching a maximum plateau of eightfold induction
already at 750 ng/mL doxycycline treatment (Supplemen-
tary Fig. S2A). Higher doses of doxycycline did not lead
to a significant increase of aSyn induction levels. Based on
these results, we confirmed 750 ng/mL doxycycline as the
optimal dose for further analyses reported in this study.
Short-term time-course analysis of doxycycline induction
on AF22 Tet-On aSyn cells (Fig. 1A) showed a progressive
increase of aSyn expression levels along with time of
doxycycline treatment (2.2-, 5.3-, and 7.9-fold induction at
24, 48, and 72 h of doxycycline treatment, respectively)
(Fig. 1B). Immunofluorescence assay performed on these
cultures showed that not all of the aSyn immunoreactive
cells exhibited the same levels of expression, with even a
fraction of the cells that barely showed any transgene ex-
pression (Fig. 1C). Quantitative analysis revealed that
72.21% – 16.64% of cells in culture were aSyn+ve, the re-
maining showing very low or undetectable aSyn immuno-
reactivity (Fig. 1D). Furthermore, the pool of aSyn+ve cells
can be divided in 30.3% – 8.21% cells exhibiting high aSyn
immunoreactivity (aSynhigh cells) and 69.67% – 8.05% cells
exhibiting low/medium aSyn immunoreactivity (aSynlow/Med
cells) (Fig. 1E).
Longer time-course analysis of doxycycline induction on
AF22 Tet-On aSyn cells (Supplementary Fig. S2B) confirmed
the progressive increase of transgene expression levels from 48
to 72 h of doxycycline induction and a strong immunoreactive
band at 12 days of induction (2.0-, 7.4-, and 13.4-fold induction
at 48 and 72 h and 12 days of doxycycline treatment,



















































respectively) (Supplementary Fig. S2C). On the whole, these
results indicate that aSyn induction in AF22 Tet-On aSyn cells
is maintained long-term and progressive in aSyn accumulation.
wt aSyn overexpression affects cell division and cell
viability in AF22 Tet-On aSyn cells
To test if aSyn induction in the cultures results in phe-
notypic abnormalities on hNSCs growth, we performed a
cell growth assay on AF22 Tet-On aSyn cells. Since aSyn
has been described to influence mitochondrial activity, we
decided to avoid mitochondrial activity-based growth as-
says. We thus performed an automated high-throughput
screening (HTS) cell count of stained cell nuclei on cultures
fixed at defined time points.
aSyn induction produced a slight reduction in cell growth
already after 72 h and this effect was more marked at later
time points (Figs. 1A and 2A), where a strong impairment in
the growth occurred (% reduction in cell number: 34.12 and
44.74 at 5 and 7 days, respectively) (Fig. 2A). These data
could be interpreted by possible effects elicited by aSyn
either on (1) cell division, (2) cell death, (3) change of fate
by induction of differentiation, or (4) a combination of the
abovementioned effects.
To dissect out which of these possibilities was prominent,
we performed specific assays. Analysis of phospho-Histone
H3+ve cells present in the cultures at different time points
(Supplementary Fig. S3) showed a reduction, although not
statistically significant, of phospho-Histone H3+ve cells oc-
curring both at 72 and 96 h of induction (Fig. 2B). A statisti-
cally significant 47.16% reduction was appreciated at 120 h
(Fig. 2B). Furthermore, a stronger statistically significant re-
duction of phospho-Histone H3+ve cells in aSyn+ve cells com-
pared with aSyn-ve cells was visible, at all the time points
considered (% of reduction of phospho-Histone H3+ve cells in
aSyn+ve cells in culture: 82.3, 96.79, and 91.54 at 3, 4, and
5 days, respectively) (Fig. 2C). These results indicate that aSyn
induction affects cell division in AF22 Tet-On aSyn cells.
Furthermore, immunofluorescent analysis for NSC markers
(Nestin and Sox2), neurons (b3-Tubulin), and astrocytes
(GFAP) indicated that more than 97% of the cells retain their
normal NSC identity without any significant induction of
neuronal or glial cells (not shown), thus indicating that
aSyn overexpression in self-renewing conditions does not
force differentiation.
To test if aSyn induction could also impact on cell sur-
vival, we performed an immunofluorescent analysis for
cleaved Caspase-3 at different time points following doxy-
cycline treatment (Supplementary Fig. S4). aSyn induction
led to a marked increase in the number of apoptotic cells in
culture (fold increase of cleaved Caspase-3+ve cells in cul-
ture: 3.31, 2.03, and 2.19 at 3, 4, and 5 days, respectively)
(Fig. 2D). Mitochondrial impairments have been explored in
many aSyn assays both in vivo and in vitro. Besides im-
paired mitochondrial function, aSyn has been demonstrated
to induce severe mitochondrial fragmentation in a number of
FIG. 1. Modulation of wt aSyn expression in AF22 Tet-On aSyn cells. (A, B) Time course of aSyn induction in AF22 Tet-
On aSyn cells treated with 750 ng/mL doxycycline. (A) Phase contrast pictures of AF22 Tet-On aSyn cells during time-
course induction of aSyn. Scale bars: upper panels 200mm; lower panels 100 mm. (B) Representative image of western blot
assays of time-course induction of aSyn. Densitometric quantification was normalized on a-tubulin expression versus
untreated cells. (C–E) Immunocytochemistry analysis for aSyn on AF22 Tet-On aSyn cells untreated and treated with
750 ng/mL doxycycline for 72 h and quantification of immunopositive cells. (C) Representative immunofluorescent images
showing aSyn+ve cells in AF22 Tet-On aSyn cultures. Hoechst was used for nuclear staining. Scale bar: 100mm. (D)
Quantification of the total number of aSyn+ve cells in basal and induced conditions. (E) Quantification of the percentage of
aSynhigh cells and aSynlow/Med cells among the overall population of aSyn+ve cells in induced AF22 Tet-On aSyn cells. aSyn,
alpha-synuclein; wt, wild-type.



















































cell culture studies. We thus explored by automated analy-
sis, mitochondria number in basal and doxycycline-treated
(5 days) cells in self-renewal condition (Fig. 2E, F and
Supplementary Fig. S5). We did not find any significant
variation on this parameter and also on mitochondrial size
(not shown) in relation to aSyn induction.
On the whole, these results indicate that aSyn over-
expression in hNSCs leads to a reduced cell growth by a
double action, both by affecting proliferation capability and
by enhancing cell death occurrence. Importantly, further
analysis is required to dissect the contribution of mito-
chondrial dysfunction to these events.
Conditional overexpression of wt aSyn leads
to the formation of intracellular aggregates
in AF22 Tet-On aSyn cells
aSyn has been shown to generate aggregates inside of the
cells and that these may contribute to cellular dysfunctions.
Immunofluorescence analysis for aSyn in AF22 Tet-On aSyn
cells following 12 days of doxycycline treatment showed that a
fraction of aSyn+ve cells exhibited punctate immunoreactive
dots in the cytoplasm (arrows in Fig. 3A). aSyn aggregates were
present both in aSynhigh cells and aSynlow/Med cells, although
the former presented higher number of aggregates with respect
to the latter (number of aggregates: 0.48– 0.19 and 3.14– 0.32
in aSynlow/Med and aSynhigh cells, respectively) (Fig. 3B). Also,
aggregates in aSynhigh cells exhibited a 5.8-fold increase in
the immunoreactive signal with respect to the ones present in
aSynmod/low cells (Fig. 3C). Furthermore, aSynhigh cells showed
a 3.1-fold increase in the parameter of area of aggregated spots
with respect to aSynmod/low cells (Fig. 3D).
To exclude that the aSyn+ve spots we detect in our cultures
might be the result of nonspecific apoptosis-related structures
instead of aggregation process, we performed a double immu-
nofluorescent staining for Cleaved Caspase-3 (Supplementary
Fig. S6). The presence of aSyn+ve spots in Cleaved Caspase-
3-ve cells (Supplementary Fig. S6) excluded this possibility,
nevertheless, additional biochemical analyses will be required
to deeper investigate the properties of these structures.
These results indicate that aSyn overexpression produces
aggregation on long-term induced AF22 Tet-On aSyn cells
and that the occurrence of aggregation is dependent on the
level of aSyn overexpression, with aSynhigh cells producing
FIG. 2. wt aSyn expression affects proliferation and cell viability of AF22 Tet-On aSyn cells. (A) Cell growth assay on
basal or induced AF22 Tet-On aSyn cells. (B, C) Quantification of time-course immunofluorescent analysis for phospho-
Histone H3 on AF22 Tet-On aSyn cells untreated or treated with 750 ng/mL doxycycline. (B) Quantification of the total
number of phospho-Histone H3 immunopositive cells at defined time points. (C) Quantification of the percentage of
phospho-Histone H3 immunopositive cells in induced AF22 Tet-On aSyn cells. (D) Quantification of time-course immu-
nofluorescent analysis for cleaved Caspase 3 on AF22 Tet-On aSyn cells treated or not with 750 ng/mL doxycycline and
relative quantification of immunoreactive cells. (E, F) Mitotracker staining on AF22 Tet-On aSyn cells treated with or
without 750 ng/mL doxycycline for 120 h and relative quantification of mitochondrial spots. (E) Quantification of the
number of spots (mitochondria) per cell. (F) Quantification of the total spot (mitochondria) area per cell. Normalization was
performed on the populations of aSyn+ve and aSyn-ve cells (B, C) or on the total number of cells (D). *P < 0.05, **P < 0.01,
****P < 0.0001. ns, non-significant.



















































more aggregated spots with greater intensity with respect to
aSynmod/low cells.
aSyn overexpression impairs neuronal
differentiation in AF22 Tet-On aSyn cells
aSyn overexpression has been indicated as a main player
in neuronal dysfunction. To test if aSyn induction in AF22
Tet-On aSyn cells could induce defects in the neuronal
differentiation potential of the cultures, AF22 Tet-On aSyn
cells (CTRL and cells maintained in doxycycline for the
entire differentiation procedure) were exposed to a 2-week
neuronal differentiation protocol. In these conditions, cells
started to show morphological changes indicative of their
progressive neuronal maturation. Immunofluorescence anal-
ysis on 14-day induced cultures showed that 73.25% – 1.97%
of the cells in culture were aSyn+ve (not shown). As ex-
pected, at this stage, not induced cultures were mainly
composed of b3-tubulin+ve neurons (% of b3-tubulin+ve
cells: 87.52 – 6.09) (Supplementary Fig. S7A) with only a
fraction of the cells in the culture positive for Map2, a
marker for mature neurons (% of Map2+ve cells: 21.14 – 4.35)
(Supplementary Fig. S7B). On the contrary, doxycycline-
treated cultures showed a 51.85% and 38.45% reduction
in the overall number of b3-tubulin+ve cells and Map2+ve
cells, respectively (Fig. 4B). These results indicate that
aSyn overexpression partially affects neuronal differen-
tiation capability of hNSCs.
We next asked if the reduction in the number of neuronal
cells is mainly due to (1) induced competence to differen-
tiate toward non-neuronal fates (ie, shift from neurogenic
versus gliogenic fate) or (2) to an impaired competence
of the cells to start the neuronal differentiation process. In
this respect, we found that aSyn overexpression induced
a 7.61-fold increase in the number of GFAP+ve cells (% of
GFAP+ve cells: 0.46 – 0.23 and 3.57 – 0.61 in not induced
and doxycycline-induced cells, respectively) (Fig. 4B and
Supplementary Fig. S7C) in the cultures, thus indicating a
possible enhanced propensity of the cells to differentiate to-
ward the astrocytic lineage. Furthermore, Sox2 immunofluo-
rescence showed the presence of large clusters of Sox2+ve
cells in the doxycycline-treated culture with a 12-fold in-
crease in the number of Sox2+ve cells, thus indicating that
aSyn overexpression increased the percentage of the cell’s
refractory to undergo neuronal differentiation process (Fig. 4B
and Supplementary Fig. S8).
FIG. 3. Conditional overexpression of wt aSyn leads to the formation of intracellular aSyn+ve aggregates in AF22 Tet-On
aSyn cells. (A–D) Immunocytochemistry analysis for aSyn on AF22 Tet-On aSyn cells treated with 750 ng/mL doxycycline
for 12 days and relative evaluation of aSyn aggregates. (A) Representative pictures of AF22 aSyn Tet-On treated with
750 ng/mL doxycycline for 12 days and stained for aSyn and Hoechst. Arrows indicate aSyn aggregates. Scale bar: 25mm.
(B) Quantification of the number of aSyn aggregates per cell in aSynLow/Medium and aSynHigh cells. (C) Quantification of the
intensity of the fluorescent signal of the aSyn aggregated spots in aSynLow/Medium- and aSynHigh-expressing cells. (D)
Quantification of the area of aSyn aggregated spots in aSynLow/Medium- and aSynHigh-expressing cells. *P < 0.05.



















































On the whole, these results indicate that there is a com-
bined effect of aSyn overexpression in disturbing hNSC
neuronal or neurogenic process.
aSyn overexpression affects cell viability in AF22
Tet-On aSyn cell-derived dopaminergic neurons
AF22 cells have the competence to differentiate toward
dopaminergic neuronal fate in defined in vitro conditions
[19]. Thus, we next analyzed the possible effects elici-
ted by aSyn acute induction in long-term differentiated
hNSC-derived dopaminergic neuronal cultures. To this aim,
self-renewing AF22 Tet-On aSyn cells were patterned for
3 weeks with FGF8/SHH and then induced to differentiate
to dopaminergic neurons for 3 weeks as previously re-
ported [19,21]. After 3 weeks of dopaminergic neuronal
maturation, cultures were mainly composed of neurons
(% of b3-tubulin+ve cells: 86.53 – 7.17), most of which were
dopaminergic neurons positive for Nurr-1 (% of Nurr-1+ve/
b3-tubulin+ve neurons: 74.43% – 8.26%) (Supplementary
Fig. S9A) and tyrosine hydroxylase (TH) (Supplementary
Fig. S9B).
At this stage, acute aSyn overexpression was achieved by
treating the cultures for 4 days with 750 ng/mL doxycycline.
aSyn overexpression produced an acute toxic effect resulting
in the degeneration of the neuronal cells in culture (% reduc-
tion of the total number of neurons in aSyn-induced cultures:
24.72– 6.13) (Supplementary Fig. S9A) and by a 1.94-fold in-
crease in the number of cleaved Caspase-3+ve cells (Fig. 5A and
Supplementary Fig. S9C). Quantitative analysis showed that the
fraction of Nurr-1+ve/b3-tubulin+ve neurons was significantly
decreased following aSyn induction (% reduction of the number
of Nurr-1+ve/b3-tubulin+ve neurons in aSyn-induced cultures:
31.72– 4.36) (Fig. 5B) with only a minor effect on the Nurr-
1-ve/b3-tubulin+ve neurons, that were not significantly affected
by acute aSyn overexpression (Fig. 5C). Thus, aSyn over-
expression impairs the survival of hNSC-derived neurons, with
dopaminergic neurons being differentially affected with respect
to nondopaminergic neuronal subtypes.
Discussion
Although aSyn is considered of relevance for PD patho-
genic process, the molecular mechanism triggering PD
FIG. 4. aSyn expression impairs neuronal differentiation of AF22 Tet-On aSyn cells. (A–C) Effects of aSyn expression on
neuronal differentiation of AF22 Tet-On aSyn cells treated or not with 750 ng/mL of doxycycline for the entire differen-
tiation process (14 DIV). (A) Quantification of the total number of b3-Tubulin+ve and Map2+ve cells on basal and induced
conditions. Values are normalized over the basal condition. (B) Quantification of the total number of GFAP+ve cells on basal
and induced conditions. (C) Quantification of the total number of Sox2+ve cells on basal and induced conditions. Values are
normalized over the number of immunoreactive cells in basal condition. *P < 0.05, **P < 0.01, ***P < 0.001.
FIG. 5. aSyn overexpression affects cell viability in AF22 Tet-On aSyn cell-derived dopaminergic neurons. (A–C) Effects
of acute aSyn induction (21–25 DIV) on AF22 Tet-On aSyn cell-derived dopaminergic neurons. (B) Quantification of the
total number of Cleaved Caspase 3+ve cells on basal and induced conditions. Values are normalized over the basal condition.
(C) Quantification of the total number of b3-Tubulin+ve/Nurr1-ve cells on basal and induced conditions. Values are
normalized over the basal condition. *P < 0.05.



















































starting from aSyn homeostasis alteration is still a matter of
debate. In this study, we report the generation of a novel
cellular model based on the overexpression of wt human
aSyn in NSCs. The system is characterized by the controlled
expression of wt human aSyn by means of a Tet-On in-
ducible mechanism and represents a valuable tool to study
the effects of aSyn overexpression in hNSCs and neurons.
The AF22 Tet-On aSyn cell model developed in this
study has several features that make it attractive for studying
the biological and molecular effects elicited by aSyn in
different developmental paradigms. These include the hNSC
nature of the parental AF22 cells. Originally, described by
Falk et al. [19], these cells have been obtained from normal
hiPSCs and show features that make them ideal as parental
cells to be engineered. Indeed, they are homogeneously
composed of self-renewing NSCs characterized by genomic
stability and high amenability to genetic manipulation. Im-
portantly, these cells maintain a stable high neurogenic ca-
pability along long-term in vitro expansion and the
competence to respond to specific patterning cues that al-
lows generating defined neuronal subtype populations, in-
cluding dopaminergic neurons.
The inducible nature of aSyn expression coupled to the
NSC system opens to the possibility to study both acute and
chronic aSyn-mediated effects in defined relevant cell
populations, that is, neural progenitors and mature neurons.
Also, this is instrumental to sort out specific effects in
several processes, including self-renewing, lineage com-
mitment, and neuronal maturation and/or maintenance.
aSyn inducible systems have been reported from different
immature parental cell lines, mainly PC12 cells and human
neuroblastoma lines [12,13,22–24]. Nonetheless, these sys-
tems have some intrinsic limitations that are overcome in
AF22 Tet-On aSyn cell model. Indeed, PC12 cells are of
rodent origin and species-specific differences in aSyn se-
quence and roles have been reported [25–27]. Additionally,
both PC12 cells and neuroblastoma lines are transformed
and share a non-CNS origin. Noteworthy, their neurogenic
potential is limited in terms of efficiency and quality of
neuronal-like cells that can be obtained following their
differentiation, thus limiting their physiological relevance
for studies aimed at dissecting aSyn roles in human CNS
neurons.
AF22 Tet-On aSyn cells show a clear dose–response
transgene expression with a robust aSyn induction up to
seven- to eightfold; also, induction can be maintained long
term leading to a progressive increase in aSyn levels. When
we tried to induce aSyn aggregation in AF22 Tet-On aSyn
cells, we found that this process requires a prolonged in-
duction period allowing to aSyn levels to increase progres-
sively. The appearance of aSyn aggregates in AF22 Tet-On
aSyn cells occurs after 12 days of induction. Other studies
performed on PC12/TetOn aSyn inducible systems failed to
observe wt aSyn aggregates in proliferating cells [22]. This
could be due to the different origins of the parental cells or
to the fact that levels of aSyn induction are lower or due to
the quite reduced time of induction with respect to our
study. Also, several reports have shown different oligomeric
aSyn forms and prion-like transmission of aSyn in vitro and
in vivo. Further investigation is required to dissect these
aspects in our cellular system, both in self-renewal and
differentiating conditions.
It is interesting to note that wt aSyn overexpression in-
duces phenotypic defects in hNSCs in the self-renewing
state. Other studies have reported that overexpression of
aSyn in the proliferating state fails to induce any cell death
in proliferating neural-like cells, despite the prominent ac-
cumulation of aSyn aggregates [12]. The factors accounting
for the differential death effects could include differences in
clearance mechanisms, or involvement of cell cycle mole-
cules or other proteins differentially expressed in the two
states.
An increasing number of studies reveal that aSyn may play
an important role in neurogenesis. When the SNCA gene is
differentially expressed or bears mutations, the in vivo NSC
pool is negatively regulated and both neurogenesis and sur-
vival of newly generated neurons are decreased [9]. These
studies suggest that a link might exist among neurogenesis,
aSyn, and neurodegenerative diseases [18].
In vitro, aSyn overexpression has been described to re-
duce the number of mouse secondary neurospheres formed
and to affect NSC morphology and cell cycle progression,
leading to their accelerated differentiation [10]. hiPSC-
derived neuronal precursor cells from a PD patient carrying
a genomic triplication of the SNCA gene showed substantial
impairments in growth, viability, cellular energy metabo-
lism, and stress resistance. These effects were exacerbated
when the cultures were challenged by starvation or toxic
stimuli [16]. Also, overexpression of wt aSyn in expanded
populations of progenitors derived from the human fetal
cortex showed a slight effect on cell growth and a pro-
gressive impairment of lineage commitment competence
[17]. Similarly, studies on human embryonic stem cell
(hESC)-derived neural progenitors overexpressing wt aSyn
and on neural progenitors obtained from hiPSCs from a PD
patient with a SCNA locus triplication, showed an increased
cell death and reduced neurogenic capacity compared with
control cultures [17,28].
Our results confirm that overexpression of human wt aSyn
impairs the process of differentiation of hNSCs into neuronal
cells. In particular, we have seen a marked reduction on the
efficiency of the cells to generate neurons when exposed to
neuronal differentiative cues with a parallel increase in the
number of astrocytes and undifferentiated cells.
Further studies are required to dissect the molecular
mechanisms triggering these specific defects. PSC-derived
long-term expandable hNSCs, including the AF 22 cells, are
highly responsive to efficiently undergo neuronal differen-
tiation when exposed to the neuronal differentiation protocol
employed in this study[19,21]. Additional investigation is
required to define if this defect is maintained when exposing
the cultures to other proneuronal differentiation conditions.
Furthermore, exposure to non-neuronal (ie, gliogenic) dif-
ferentiation cues could help to understand if the observed
refractoriness to exit self-renewal is specific for the transi-
tion toward the neuronal lineage or is a more general aSyn-
mediated effect. Finally, we cannot exclude aSyn-selective
toxicity toward specific cell types might contribute to these
alterations. Besides this, we have in this study reported an
aSyn-driven effect on hNSCs neurogenic process that results
in increased number of astrocytes found in neuronally dif-
ferentiating cultures.
Other studies have reported that wt aSyn overexpression
in human neural progenitors derived from fetal cortex



















































preserved the neurogenic competence of the cells following
long-term expansion [17]. To this respect, we can speculate
that this discrepancy might be related to the different nature
and identity between our and the abovementioned cell sys-
tem. Indeed, differently from fetal brain-derived cell sys-
tems that are representative of late developmental neural
stages and in which the neurogenic competence quickly
declines with in vitro passages, the PSC-derived hNSCs we
employed are representative of earlier developmental neural
stages and are extremely stable also following extensive
long-term expansion [29].
Finally, we have observed an aSyn-mediated acute toxicity
in hNSC-derived neurons, being dopaminergic neurons se-
lectively affected. These results are in agreement with a
previous study reporting acute aSyn toxicity in hESC-
derived neuronal cultures [17]. Those authors showed that
hESC-derived neuronal cultures are highly vulnerable to
expression of both wt aSyn or mutant aSyn forms, with
dopaminergic neurons exhibiting higher toxic suscepti-
bility with respect to nondopaminergic (GABAergic) neu-
rons. It is yet unclear the reason of this neuronal subtype’s
selective cytotoxicity. The factors accounting for this
differential death effects in different neuronal subtypes
are unknown but could include differences in clearance
mechanisms or other proteins differentially expressed in
the two states. Interestingly, aSyn overexpression has
been shown to directly affect TH expression, suggesting
possible direct TH effects [30]. Regardless of the exact
reason, this fact further validates the current model as one
in which toxic effects occur preferentially in dopaminer-
gic neurons.
In conclusion, we have developed a cell system for con-
trolled expression of wt aSyn in hNSCs that exhibit defined
aSyn-driven phenotypes both in self-renewal and differen-
tiating/differentiated stages. This novel inducible model
may prove valuable in the deciphering of aSyn-mediated
pathogenic effects and in the assessment and screening of
potential therapeutic strategies.
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SUPPLEMENTARY FIG. S1. b AU13Evaluation of aSyn induction in AF22 Tet-On aSyn cultures selected by means of
different doses of puromycin (upper panel). Phase contrast images of AF22 Tet-On aSyn cells selected with different doses
of puromycin and treated or not with 750 ng/mL of doxycycline for 72 h. Scale bar: 100 mm (lower panel). Representative
image of a western blot analysis of the cells in (A). Densitometric quantification was normalized on a-tubulin expression
and versus untreated cells. aSyn, alpha-synuclein.










SUPPLEMENTARY FIG. S2. Evaluation of dose–re-
sponse and long-term aSyn induction in AF22 Tet-On aSyn
cultures. (A) Dose-dependent aSyn induction in AF22 Tet-
On aSyn cells treated with or without doxycycline for 72 h
and relative densitometric quantification normalized on a-
tubulin expression and versus untreated control. (B) Phase
contrast pictures of AF22 Tet-On aSyn cultures treated with
or without 750 ng/mL doxycycline for the indicated time.
Scale bar: 100mm. (C) Kinetics of aSyn induction of AF22
Tet-On aSyn cells treated with 750 ng/mL doxycycline for
the indicated time showing a time-dependent accumulation
of aSyn levels. Expression is maintained in long-term in-
duced (12AU14 c DIV) cultures.
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SUPPLEMENTARY FIG. S3. wt aSyn overexpression affects proliferation of AF22 Tet-On aSyn cells. Time course
immunofluorescent analysis for phospho-Histone H3 on doxycycline-treated AF22 Tet-On aSyn cells with 750 ng/mL
doxycycline and relative quantification of immunopositive cells. Representative pictures of AF22 Tet-On aSyn cells stained
for phospho-Histone H3. Hoechst was used for nuclear staining. Scale bar: 200mm. wt, wild-type.
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SUPPLEMENTARY FIG. S4. wt aSyn overexpression affects cell viability in AF22 Tet-On aSyn cells. Representative
pictures of uninduced or induced AF22 Tet-On aSyn cells stained for cleaved Caspase-3. Hoechst was used for nuclear
staining. Scale bar: 200 mm.








SUPPLEMENTARY FIG. S5. wt aSyn overexpression does not affect mitochondrial number in self-renewing AF22 Tet-
On aSyn cells. Mitotracker staining of AF22 Tet-On aSyn cells treated with or without 750 ng/mL doxycycline for 120 h
and relative quantification of mitochondrial spots. (A) Representative pictures of cultures stained for Mitotracker, Cell
Mask, and nuclei. (B) Overlay of stained cells with ROIs for quantifying mitochondria. ROIs, regions of interest.
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SUPPLEMENTARY FIG. S6. aSyn immunoreactive aggregates do not colocalize with cleaved Caspase-3. Im-
munocytochemistry analysis for aSyn and cleaved Caspase-3 of AF22 Tet-On aSyn cells treated with or without 750 ng/mL
doxycycline for 72 h. (A, B) Representative pictures of cultures stained for aSyn, cleaved Caspase-3, and nuclei. Arrow-
heads indicates aSyn+ve aggregates that are negative for cleaved Caspase-3.







SUPPLEMENTARY FIG. S7.AU15 c Expression of aSyn dis-
turbs neuronal differentiation of AF22 Tet-On aSyn cells.
(A–C) Effects of aSyn expression on neuronal differentia-
tion of AF22 Tet-On aSyn cells treated or not with 750 ng/
mL of doxycycline for the entire differentiation process (14
DIV). (A) Representative pictures of b3-Tubulin+ve cells on
14 DIV cultures of basal and induced AF22 Tet-On aSyn
cultures. (B) Representative pictures of Map2+ve cells on 14
DIV cultures of basal and induced AF22 Tet-On aSyn cul-
tures. (C) Representative pictures of GFAP+ve astrocytes on
14 DIV cultures of basal and induced AF22 Tet-On aSyn
cultures. Hoechst was used for nuclear staining. Scale bar:
100 mm (C).






SUPPLEMENTARY FIG. S8. aSyn induction increases the number of undifferentiated cells in AF22 Tet-On aSyn cells
undergoing neuronal differentiation process. Effects of aSyn expression on neuronal differentiation of AF22 Tet-On aSyn
cells treated or not with 750 ng/mL of doxycycline for the entire differentiation process (14 DIV). Representative pictures of
sox2+ve cells on DIV 14 cultures of basal and induced AF22 Tet-On aSyn cultures. The presence of clusters of sox2+ve cells
is visible in induced cultures. Hoechst was used for nuclear staining. Scale bar: 100mm.
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SUPPLEMENTARY FIG. S9. Acute aSyn induction impairs AF22 Tet-On aSyn cell-derived dopaminergic neuron
viability. Effects of acute aSyn induction (21–25 DIV) on AF22 Tet-On aSyn cell-derived dopaminergic neurons. (A)
Representative pictures of b3-Tubulin+ve and Nurr1+ve cells in 25 DIV cultures. (B) Representative pictures of TH+ve and
aSyn+ve cells in 25 DIV cultures. (C) Representative pictures of Cleaved Caspase 3+ve and aSyn+ve cells in 25 DIV cultures.
Hoechst was used for nuclear staining. Hoechst was used for nuclear staining. Scale bar: 100 mm.




Supplementary Table S1. List of Primary and Secondary Antibodies Used in the Study
Antigen Company Dilution Species
Alpha-synuclein Sigma 1:1,000–1:500 Mouse
b3-Tubulin Promega 1:1,000 Mouse
GFAP DAKO 1:1,000 Mouse
Sox2 Millipore 1:300 Rabbit
Phospho-histone H3 Chemicon/Millipore 1:500 Rabbit
Cleaved caspase 3 Cell Signaling Technology 1:1,000 Rabbit
Map2 Millipore 1:300 Rabbit
Nurr-1 Santa Cruz Biotechnologies 1:100 Rabbit
TH Sigma 1:500 Rabbit
Alexa Fluor IgG anti-rabbit 568 Molecular Probes 1:500 Goat
Alexa Fluor IgG anti-rabbit 488 Molecular Probes 1:500 Goat
Immunostar anti-mouse HRP Bio-Rad 1:2,000 Goat
Immunostar anti-rabbit HRP Bio-Rad 1:2,000 Goat
HRP, horseradish peroxidase.
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